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Abstract: In dieser Doktorarbeit wird die Depression im Rahmen der zirkadianen und homöostatis-
chen Schlaf-Wach-Regulation untersucht. Wie wirken sich diese zwei unabhängigen und nicht additiven
Systeme auf die Stimmung, die subjektive Schläfrigkeit, subjektive Anspannung, das Wach-EEG, die
Melatoninkonzentration, und die kognitive Leistungsfähigkeit bei jungen depressiven Frauen ohne Insom-
nie unter zwei verschiedenen Schlafdruckbedingungen aus? Verschiedene Untersuchungen weisen auf eine
Beteiligung respektive einer ungünstigen Interaktion der Schlafhomöostase und des endogenen zirkadia-
nen Systems bei der Entstehung von depressiven Erkrankungen hin. Überraschenderweise wurden bis jetzt
sehr wenige Studien unter standardisierten kontrollierten Laborbedingungen bei der Majoren Depression
(MDD) durchgeführt. Das Studiendesign besteht aus zwei verschiedenen Protokollen und wurde unter
„Constant Routine“ - Bedingungen durchgeführt; beide beginnen mit einer Baselinenacht und schliessen
mit einer Erholungsnacht ab. Die 40 Stunden zwischen diesen beiden Nächten bestehen entweder aus
einer Episode mit totaler Schlafdeprivation (SD; hoher Schlafdruck) oder aus 10 Schlaf/Wach-Zyklen
von 75 min. Schlaf, gefolgt von 150 min. Wachsein (Nap Protokoll; tiefer Schlafdruck). Das erste Ziel
dieser Doktorarbeit (Kapitel 2) war die Untersuchung der zirkadianen und schlaf-wach-homöostatischen
Veränderungen in der subjektiven Befindlichkeit an gesunden Menschen. Die Interaktion dieser bei-
den Prozesse wurde unter zwei verschiedenen Schlafdruckbedingungen mit der Frage nach Geschlechts-
und Altersunterschieden untersucht. Generell zeigten Frauen eine schlechtere subjektive Befindlichkeit
und ein markanteres zirkadianes Stimmungstief unter Schlafdeprivation. Im Vergleich zu den Jüngeren
wurde bei älteren Menschen unter diesen Studienbedingungen eine schlechtere subjektive Befindlichkeit
gemessen. Diese Resultate zeigen, dass sich das zirkadiane System sowie die Schlaf-Wach-Homöostase
geschlechts- und alterspezifisch auf die subjektive Befindlichkeit auswirken. In einem weiteren Schritt
wurde die Auswirkung der Interaktion der zirkadianen und schlaf- wach-homöostatischen Prozessen auf
verschiedene Parameter bei jungen Frauen mit einer Episode einer Majoren Depression unter hohen und
tiefen Schlafdruckbedingen untersucht. Die Hypothese, dass Depression auf einen Mangel im schlaf-
wach-homöostatischen Prozess zurückführt (d.h. die S-Defizient-Hypothese) wurde im zweiten Beitrag
(Kapitel 3) mittels Wach-EEG während anhaltender Wachheit überprüft. Gleichzeitig wurde die subjek-
tive Schläfrigkeit, subjektive Anspannung und die Melatoninkonzentration im Speichel untersucht. Im
Gegensatz zur postulierten Defizienz des homöostatischen Prozesses („Schlafdruckmanko“), zeigten sich
erhöhte langsamwellige EEG Anteile (Deltaband von 2 bis 5 Hz) während des Wachseins (SD Protokoll)
vor allem in frontalen Hirnregionen mit gleichzeitig erhöhter Schläfrigkeit und subjektiver Anspannung
sowie einer verringerten nächtlichen Melatoninausschüttung. Diese Resultate lassen vermuten, dass de-
pressive Frauen auf einem höheren Schlafdruckniveau „leben“. Somit könnte eher von einer Übersteuerung
der Schlaf-Wach-Homöostase gesprochen werden. Im dritten Beitrag (Kapitel 4) wird der Fokus auf
tageszeitliche Stimmungsschwankungen in der Depression gelegt. Ausgehend von den Kenntnissen über
Schlafentzugsbehandlungen bei Depressiven wurde bei den jungen depressiven Frauen ein möglicher stim-
mungsaufhellender Effekt unter hohen Schlafdruckbedingungen untersucht. Die Daten zeigen, dass de-
pressive Frauen ohne Schlafstörungen im Schlafdeprivationsprotokoll einen signifikant unterschiedlicheren
Stimmungsverlauf im Vergleich zu den gesunden jungen Frauen zeigen. Trotz dieser ausgeprägten Stim-
mungsschwankung konnten die jungen depressiven Frauen nicht von einem antidepressiven Effekt profi-
tieren. Diese Ergebnisse weisen darauf hin, dass der mögliche Profit einer Schlafdeprivationsbehandlung
vom Ausmass des Vorhandenseins der Schlafstörung bei Depressiven abhängig ist. Im letzten Beitrag
(Kapitel 5) wurde der Einfluss von hohem und tiefem Schlafdruck auf die kognitive Leistung bei Depres-
siven mittels Psychomotorischen Vigilanztest (PVT) untersucht. Unerwarteterweise zeigte sich bei den
jungen depressiven Frauen eine schnellere Reaktionszeit im PVT während der Schlafdeprivation. Dies
könnte auf eine geringere Anfälligkeit auf wachheitsabhängige nachteilige Aspekte bei der Leistung des
PVT schliessen lassen. Aus den Ergebnissen dieser Arbeit lässt sich schliessen, dass in der Interaktion
des zirkadianen und schlaf-wach-homöostatischen Prozesses unter streng kontrollierten Bedingungen und
bei einem mittleren Chronotyp, depressive junge Frauen deutliche Unterschiede zu den gesunden jungen
Frauen aufweisen. Die Resultate im schlaf-wach- homöostatischen Prozess sind anders als erwartet, und
haben in der Interaktion möglicherweise einen grösseren Einfluss als bisher angenommen. Für die Be-
handlung der Depression könnte aufgrund dieser Resultate die Verabreichung von Licht am Morgen zur
Reduktion der Schläfrigkeit und der Erhöhung der Melatoninamplitude hilfreich sein. There is mount-
ing evidence supporting the role of the sleep-wake cycle and the endogenous circadian system in the
pathogenesis of the disorder of major depression. Surprisingly, very little research has been done so far
with the focus on basic investigations under unmasked standard controlled conditions to avoid masking
effects in Major Depression Disorder (MDD). In this thesis, the theoretical framework that underpins
depression is addressed within the context of the circadian and sleep-wake homeostatic regulation, and
on how these two independent and non-additive systems impact mood, subjective sleepiness, melatonin
and waking EEG in young depressed women without sleep disturbances. The study design consisted of
two different protocols; both started with a baseline and ended with a recovery night. The 40-h episode
between these two nights comprised either an episode of total sleep deprivation (SD; high sleep pressure)
or 10 sleep/wake cycles with 75 min of sleep followed by 150 min of wakefulness (nap protocol; low sleep
pressure). In this thesis the focus is on the response of the different parameters of the episodes during the
SD protocol and, furthermore, a comparison is made of the courses of both protocols. The first aim of this
thesis was to gain comprehensive information about a basic model to quantify circadian and sleep-wake
related changes in subjective and objective variables in healthy volunteers to understand what normal
daily variations of this parameters look like. In this regard, subjective well-being, subjective sleepiness,
melatonin and cortisol levels (Chapter 2) were first compared among two different age and gender groups
of healthy participants under unmasked conditions in a high and low sleep pressure protocol. The time
course of subjective well-being shows a circadian rhythm under low and high sleep pressure conditions.
Furthermore, we could show that the well known circadian regulation of subjective sleepiness, melatonin
and cortisol are clearly age and gender dependent in healthy adult volunteers. Time of day modulation
of subjective well-being was prominent in both the SD and the nap protocol, indicating that circadian
phase plays a pivotal role in well-being. In general, and as a new interesting finding, both older adults
and women were more affected by SD, showing a tendency to lower subjective well-being and a prominent
circadian trough. The time course of subjective well-being displayed a significant circadian modulation,
particularly in women under high sleep pressure conditions. The hypothesis that depression could be
linked to a deficiency in the sleep-wake homeostatic process (i.e. the so-called S-deficiency hypothesis)
was tested by waking EEG recordings during sustained wakefulness along with assessment of subjective
sleepiness, tension and salivary melatonin (Chapter 3). In contrast to a deficiency of the homeostatic
process (i.e. S- deficiency), our results indicated that depressive women might live on a higher level of
homeostatic sleep pressure, as indexed by enhanced high frontal-low EEG activity (delta range from 2 to
5 Hz) during sustained wakefulness in the SD protocol. This finding of a higher sleep pressure in depres-
sives was also supported with sleep recording results that showed a tendency to have higher sleep pressure
levels during the nap protocol. Along these lines, we have evidence for significantly higher EEG slow-wave
activity (delta EEG activity) levels in Non-REM (NREM) sleep in our depressed cohort during baseline
and recovery sleep in both the SD and the nap protocol. Chapter 4 focuses on diurnal variations of mood
and whether there is an antidepressant effect of SD. The data show that depressive women without sleep
disturbances show a significantly different time course of mood during the SD protocol but not during nap
protocol. Under SD they exhibited a more distinct circadian modulation of lower mood than controls. In
their diurnal modulation they showed morning worsening and evening improvement, which corresponds
to the so-called melancholic type. Despite this higher variability of mood fluctuation and characteristic
of a more melancholic type as a predictor of SD response, surprisingly and in contrast to our hypothesis,
they did not profit from an antidepressant effect. These findings indicate that the possible benefit of
SD treatment could depend on the magnitude of insomnia in depression. In a final step, in Chapter 5,
we focused on the influence of high and low sleep pressure conditions on neurobehavioral performance
in depressed patients using the psychomotor vigilance task (PVT). These results yielded an unexpected
finding: depressed women had faster reaction times (RT) in PVT performance during SD. This may imply
that depressed women are less susceptible to the wake-dependent aspects in PVT performance. Taken
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together, this thesis provides several surprising data in our cohort of MDD women that stand in contrast
to some of the long-standing mainstream hypothesis (chapters 3–5). Overall, the homeostatic process
seems to override young women with major depression disorder, as indicated by enhanced high frontal
low-EEG activity. The depressed reported higher subjective sleepiness and had lower salivary melatonin,
detected during a biological night, indicating that they did not profit from the antidepressant effect yet
performed faster in PVT during SD. The waking EEG data suggests that the sleep-wake homeostat of the
depressed is more an overdrive than an S-deficiency, which probably corresponds to the clinically reported
day time fatigue. Depressed women who live on a higher level of sleep pressure do not profit from the
antidepressant effect of SD and perform faster in a reaction time task than controls. This leads to the
assumption that the excluded factors in this protocol (chronotype, insomnia) may exert a strong influence
on these results. The suggestion that hypocretin neurons stabilise arousal/alertness during periods of
wakefulness and increase arousal-related behaviours can be interpreted as having an endogenous stressor
effect. The heuristic model of emotional and physiological hyperarousal hypothesis must be assumed,
and the depressive cohort in our study suffered only a minor hyperarousal, which probably affects frontal
delta activity, leading to a higher sleep pressure but is not strong enough to cause sleep disturbances. The
postulated abnormalities (i.e. phase-shift, sleep disturbances) in the biological rhythms seem to undergo
less dramatic differences in the young depressed women who were investigated in this thesis; hence, it
can be assumed that the homeostatic process seems to have more influence than previously thought.
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ZUSAMMENFASSUNG 
 
In dieser Doktorarbeit wird die Depression im Rahmen der zirkadianen und homöostatischen 
Schlaf-Wach-Regulation untersucht. Wie wirken sich diese zwei unabhängigen und nicht 
additiven Systeme auf die Stimmung, die subjektive Schläfrigkeit, subjektive Anspannung, 
das Wach-EEG, die Melatoninkonzentration, und die kognitive Leistungsfähigkeit bei jungen 
depressiven Frauen ohne Insomnie unter zwei verschiedenen Schlafdruckbedingungen aus? 
Verschiedene Untersuchungen weisen auf eine Beteiligung respektive einer ungünstigen 
Interaktion der Schlafhomöostase und des endogenen zirkadianen Systems bei der Entstehung 
von depressiven Erkrankungen hin. Überraschenderweise wurden bis jetzt sehr wenige 
Studien unter standardisierten kontrollierten Laborbedingungen bei der Majoren Depression 
(MDD) durchgeführt. 
Das Studiendesign besteht aus zwei verschiedenen Protokollen und wurde unter „Constant 
Routine“ - Bedingungen durchgeführt; beide beginnen mit einer Baselinenacht und schliessen 
mit einer Erholungsnacht ab. Die 40 Stunden zwischen diesen beiden Nächten bestehen 
entweder aus einer Episode mit totaler Schlafdeprivation (SD; hoher Schlafdruck) oder aus 10 
Schlaf/Wach-Zyklen von 75 min. Schlaf, gefolgt von 150 min. Wachsein (Nap Protokoll; 
tiefer Schlafdruck).     
Das erste Ziel dieser Doktorarbeit (Kapitel 2) war die Untersuchung der zirkadianen und 
schlaf-wach-homöostatischen Veränderungen in der subjektiven Befindlichkeit an gesunden 
Menschen. Die Interaktion dieser beiden Prozesse wurde unter zwei verschiedenen 
Schlafdruckbedingungen mit der Frage nach Geschlechts- und Altersunterschieden 
untersucht. Generell zeigten Frauen eine schlechtere subjektive Befindlichkeit und ein 
markanteres zirkadianes Stimmungstief unter Schlafdeprivation. Im Vergleich zu den 
Jüngeren wurde bei älteren Menschen unter diesen Studienbedingungen eine schlechtere 
subjektive Befindlichkeit gemessen. Diese Resultate zeigen, dass sich das zirkadiane System 
sowie die Schlaf-Wach-Homöostase geschlechts- und alterspezifisch auf die subjektive 
Befindlichkeit auswirken.  
In einem weiteren Schritt wurde die Auswirkung der Interaktion der zirkadianen und schlaf-
wach-homöostatischen Prozessen auf verschiedene Parameter bei jungen Frauen mit einer 
Episode einer Majoren Depression unter hohen und tiefen Schlafdruckbedingen untersucht.  
Die Hypothese, dass Depression auf einen Mangel im schlaf-wach-homöostatischen Prozess 
zurückführt (d.h. die S-Defizient-Hypothese) wurde im zweiten Beitrag (Kapitel 3) mittels 
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Wach-EEG während anhaltender Wachheit überprüft. Gleichzeitig wurde die subjektive 
Schläfrigkeit, subjektive Anspannung und die Melatoninkonzentration im Speichel 
untersucht. Im Gegensatz zur postulierten Defizienz des homöostatischen Prozesses 
(„Schlafdruckmanko“), zeigten sich erhöhte langsamwellige EEG Anteile (Deltaband von 2 
bis 5 Hz) während des Wachseins (SD Protokoll) vor allem in frontalen Hirnregionen mit 
gleichzeitig erhöhter Schläfrigkeit und subjektiver Anspannung sowie einer verringerten 
nächtlichen Melatoninausschüttung. Diese Resultate lassen vermuten, dass depressive Frauen 
auf einem höheren Schlafdruckniveau „leben“. Somit könnte eher von einer Übersteuerung 
der Schlaf-Wach-Homöostase gesprochen werden.  
Im dritten Beitrag (Kapitel 4) wird der Fokus auf tageszeitliche Stimmungsschwankungen in 
der Depression gelegt. Ausgehend von den Kenntnissen über Schlafentzugsbehandlungen bei 
Depressiven wurde bei den jungen depressiven Frauen ein möglicher stimmungsaufhellender 
Effekt unter hohen Schlafdruckbedingungen untersucht. Die Daten zeigen, dass depressive 
Frauen ohne Schlafstörungen im Schlafdeprivationsprotokoll einen signifikant 
unterschiedlicheren Stimmungsverlauf im Vergleich zu den gesunden jungen Frauen zeigen. 
Trotz dieser ausgeprägten Stimmungsschwankung konnten die jungen depressiven Frauen 
nicht von einem antidepressiven Effekt profitieren. Diese Ergebnisse weisen darauf hin, dass 
der mögliche Profit einer Schlafdeprivationsbehandlung vom Ausmass des Vorhandenseins 
der Schlafstörung bei Depressiven abhängig ist. 
Im letzten Beitrag (Kapitel 5) wurde der Einfluss von hohem und tiefem Schlafdruck auf die 
kognitive Leistung bei Depressiven mittels Psychomotorischen Vigilanztest (PVT) 
untersucht. Unerwarteterweise zeigte sich bei den jungen depressiven Frauen eine schnellere 
Reaktionszeit im PVT während der Schlafdeprivation. Dies könnte auf eine geringere 
Anfälligkeit auf wachheitsabhängige nachteilige Aspekte bei der Leistung des PVT schliessen 
lassen.  
Aus den Ergebnissen dieser Arbeit lässt sich schliessen, dass in der Interaktion des 
zirkadianen und schlaf-wach-homöostatischen Prozesses unter streng kontrollierten 
Bedingungen und bei einem mittleren Chronotyp, depressive junge Frauen deutliche 
Unterschiede zu den gesunden jungen Frauen aufweisen. Die Resultate im schlaf-wach-
homöostatischen Prozess sind anders als erwartet, und haben in der Interaktion 
möglicherweise einen grösseren Einfluss als bisher angenommen.  
Für die Behandlung der Depression könnte aufgrund dieser Resultate die Verabreichung von 
Licht am Morgen zur Reduktion der Schläfrigkeit und der Erhöhung der Melatoninamplitude 
hilfreich sein. 
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SUMMARY 
 
There is mounting evidence supporting the role of the sleep-wake cycle and the endogenous 
circadian system in the pathogenesis of the disorder of major depression. Surprisingly, very 
little research has been done so far with the focus on basic investigations under unmasked 
standard controlled conditions to avoid masking effects in Major Depression Disorder 
(MDD). In this thesis, the theoretical framework that underpins depression is addressed within 
the context of the circadian and sleep-wake homeostatic regulation, and on how these two 
independent and non-additive systems impact mood, subjective sleepiness, melatonin and 
waking EEG in young depressed women without sleep disturbances.  
The study design consisted of two different protocols; both started with a baseline and ended 
with a recovery night. The 40-h episode between these two nights comprised either an episode 
of total sleep deprivation (SD; high sleep pressure) or 10 sleep/wake cycles with 75 min of 
sleep followed by 150 min of wakefulness (nap protocol; low sleep pressure). In this thesis 
the focus is on the response of the different parameters of the episodes during the SD protocol 
and, furthermore, a comparison is made of the courses of both protocols. 
The first aim of this thesis was to gain comprehensive information about a basic model to 
quantify circadian and sleep-wake related changes in subjective and objective variables in 
healthy volunteers to understand what normal daily variations of this parameters look like. In 
this regard, subjective well-being, subjective sleepiness, melatonin and cortisol levels 
(Chapter 2) were first compared among two different age and gender groups of healthy 
participants under unmasked conditions in a high and low sleep pressure protocol. The time 
course of subjective well-being shows a circadian rhythm under low and high sleep pressure 
conditions. Furthermore, we could show that the well known circadian regulation of 
subjective sleepiness, melatonin and cortisol are clearly age and gender dependent in healthy 
adult volunteers. Time of day modulation of subjective well-being was prominent in both the 
SD and the nap protocol, indicating that circadian phase plays a pivotal role in well-being. In 
general, and as a new interesting finding, both older adults and women were more affected by 
SD, showing a tendency to lower subjective well-being and a prominent circadian trough. The 
time course of subjective well-being displayed a significant circadian modulation, particularly 
in women under high sleep pressure conditions.  
The hypothesis that depression could be linked to a deficiency in the sleep-wake homeostatic 
process (i.e. the so-called S-deficiency hypothesis) was tested by waking EEG recordings 
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during sustained wakefulness along with assessment of subjective sleepiness, tension and 
salivary melatonin (Chapter 3). In contrast to a deficiency of the homeostatic process (i.e. S-
deficiency), our results indicated that depressive women might live on a higher level of 
homeostatic sleep pressure, as indexed by enhanced high frontal-low EEG activity (delta 
range from 2 to 5 Hz) during sustained wakefulness in the SD protocol. This finding of a 
higher sleep pressure in depressives was also supported with sleep recording results that 
showed a tendency to have higher sleep pressure levels during the nap protocol. Along these 
lines, we have evidence for significantly higher EEG slow-wave activity (delta EEG activity) 
levels in Non-REM (NREM) sleep in our depressed cohort during baseline and recovery sleep 
in both the SD and the nap protocol. 
Chapter 4 focuses on diurnal variations of mood and whether there is an antidepressant effect 
of SD. The data show that depressive women without sleep disturbances show a significantly 
different time course of mood during the SD protocol but not during nap protocol. Under SD 
they exhibited a more distinct circadian modulation of lower mood than controls. In their 
diurnal modulation they showed morning worsening and evening improvement, which 
corresponds to the so-called melancholic type. Despite this higher variability of mood 
fluctuation and characteristic of a more melancholic type as a predictor of SD response, 
surprisingly and in contrast to our hypothesis, they did not profit from an antidepressant 
effect. These findings indicate that the possible benefit of SD treatment could depend on the 
magnitude of insomnia in depression. 
In a final step, in Chapter 5, we focused on the influence of high and low sleep pressure 
conditions on neurobehavioral performance in depressed patients using the psychomotor 
vigilance task (PVT). These results yielded an unexpected finding: depressed women had 
faster reaction times (RT) in PVT performance during SD. This may imply that depressed 
women are less susceptible to the wake-dependent aspects in PVT performance.  
Taken together, this thesis provides several surprising data in our cohort of MDD women that 
stand in contrast to some of the long-standing mainstream hypothesis (chapters 3–5). Overall, 
the homeostatic process seems to override young women with major depression disorder, as 
indicated by enhanced high frontal low-EEG activity. The depressed reported higher 
subjective sleepiness and had lower salivary melatonin, detected during a biological night, 
indicating that they did not profit from the antidepressant effect yet performed faster in PVT 
during SD. The waking EEG data suggests that the sleep-wake homeostat of the depressed is 
more an overdrive than an S-deficiency, which probably corresponds to the clinically reported 
day time fatigue. Depressed women who live on a higher level of sleep pressure do not profit 
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from the antidepressant effect of SD and perform faster in a reaction time task than controls. 
This leads to the assumption that the excluded factors in this protocol (chronotype, insomnia) 
may exert a strong influence on these results. The suggestion that hypocretin neurons stabilise 
arousal/alertness during periods of wakefulness and increase arousal-related behaviours can 
be interpreted as having an endogenous stressor effect. The heuristic model of emotional and 
physiological hyperarousal hypothesis must be assumed, and the depressive cohort in our 
study suffered only a minor hyperarousal, which probably affects frontal delta activity, 
leading to a higher sleep pressure but is not strong enough to cause sleep disturbances. The 
postulated abnormalities (i.e. phase-shift, sleep disturbances) in the biological rhythms seem 
to undergo less dramatic differences in the young depressed women who were investigated in 
this thesis; hence, it can be assumed that the homeostatic process seems to have more 
influence than previously thought. 
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CHAPTER 1 
 
Theoretical Background 
Introduction 
There is mounting evidence supporting the role of the sleep-wake cycle and the endogenous 
circadian system in the pathogenesis of the disorder of major depression. In general, several 
psychiatric disorders like unipolar depression, bipolar disorder, seasonal affective disorder 
and anxiety-related disorders have been associated with circadian abnormalities (Boivin 2000; 
McClung 2007; Roybal, Theobold et al. 2007). Disturbed circadian rhythms such as diurnal 
variation of mood and sleep belong to the major symptoms of depressive patients. The first 
studies of clock genes in major depression were negative (Desan, Oren et al. 2000). Thus, it is 
still not clear if alterations in circadian clock gene expression play a significant role in 
depression. Disorders of the human circadian system can result in circadian misalignment, 
which itself causes sleep disturbances, reduced attention, impaired daytime alertness, fatigue, 
lack of energy, memory problems, abnormal negative mood and gastrointestinal disorders. 
Interestingly, all these neuropsychiatric symptoms also occur in depression and are classified 
in the international diagnosis systems.  
Surprisingly very little research has been done so far with the focus on basic investigations 
under unmasked standard controlled conditions to avoid masking effects in depression. Most 
clinical and basic investigations on circadian alterations in depression have focussed on the 
subgroup of Seasonal Affective Disorder (SAD). From these studies, concepts of “susceptible 
circadian phases”, during which sudden shifts in circadian rhythms lead to depression in 
predisposed individuals, was initially proposed by Papousek and colleagues (Papousek 1975) 
and refined by Wehr and Wirz-Justice (Wehr and Wirz-Justice 1982) and others (see for 
review (Wirz-Justice 1995)). Earlier sleep laboratory investigations yielded an association 
between abnormal sleep patterns including shortened REM latency and early morning 
awakening with major depression (Gillin, Duncan et al. 1979). However, newer sleep studies 
including the spectral analyses of the sleep EEG in depression could not confirm earlier data 
(Koorengevel, Beersma et al. 2002) (Landolt and Gillin 2005). 
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The two-process models of sleep regulation 
Sleep homeostasis regulates the balance between sleep and waking. Two interacting 
processes, a homeostatic process S and a circadian process C have been postulated to regulate 
sleep and wakefulness (Borbely 1982; Daan, Beersma et al. 1984). Biological rhythms are 
periodical temporal variations, statistically proved, foreseeable and recognizable. The two 
main processes characterizing the sleep-wake regulation are; a homeostatic process S 
describing the sleep-pressure's course during wake-time and its lowering during sleep; a 
circadian process C with a period length of about 24 hours. Both processes influence a third 
one, the so-called ultradian process, which regulates the structure of sleep cycles, presented in 
Figure 1.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Schematic representation of the homeostatic and circadian processes; as well as the ultradian 
process during sleep: W, waking; S, sleep; N, NREM sleep; R, REM sleep. The progressive decline of NREM 
intensity is represented both in the top and bottom diagrams (decline of ultradian amplitude). The increase in the 
duration of successive REM sleep episodes is indicated (Figure modified from (Achermann and Borbely 1992)). 
 
The sleep homeostatic process 
Process S, the homeostatic pressure for sleep progressively increases as an exponential 
saturating function during waking and dissipates as an exponential function during the 
following sleep episode. The extent of homeostatic sleep pressure directly depends on the 
duration of prior wakefulness (Borbely, Baumann et al. 1981; Dijk, Beersma et al. 1987). 
Therefore, S represents an hourglass process. The term “sleep homeostasis” (Borbely, 
Steigrad et al. 1980) was proposed to characterize the sleep-wake dependent aspect of sleep 
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regulation. Characteristics of the homeostatic process as a measurement are low frequency 
components such as EEG theta activity (4.5-8 Hz) during wakefulness (Cajochen, Khalsa et 
al. 1999; Finelli, Baumann et al. 2000; Cajochen, Knoblauch et al. 2001) and the EEG slow-
wave activity (SWA; 0.75-4.5 Hz) during sleep (Borbely, Baumann et al. 1981), (Werth, 
Achermann et al. 1997; Cajochen, Foy et al. 1999; Finelli, Borbely et al. 2001). Changes in 
homeostatic sleep regulation can be quantified by spectral EEG correlates in the low 
frequency range (1-7 Hz) during sleep and during wakefulness (Aeschbach, Matthews et al. 
1997; Aeschbach, Matthews et al. 1999; Finelli, Baumann et al. 2000; Makeig, Jung et al. 
2000; Cajochen, Wyatt et al. 2002). 
Diverse predictive mathematical models have been developed to simulate process S (Borbely 
and Achermann 1992; Achermann, Dijk et al. 1993; Beersma 1998). Little is known about the 
brain structures involved in process S, and it seems that not only one but several neural 
correlates for S exist (Borbely and Tobler 1989; Harris 2005), such as adenosine activity from 
neuroglia cells (Jones 2009) that increase during prolonged wakefulness (Porkka-Heiskanen, 
Strecker et al. 1997; Latini and Pedata 2001). This could explain the sleep-inducing effect of 
SD. Caffeine has an antagonistic effect on adenosine receptors. In a recent study it could be 
shown that caffeine reduces the power density in the lowest delta band (Landolt, Dijk et al. 
1995). This corroborates the potential major role of adenosine in the sleep homeostatic 
process. 
 
The circadian System 
On the other hand, process C, the circadian process, oscillates with a period of about 24 
hours. It represents a clock-like process independent of whether one is asleep or awake and 
needs to be synchronized with external time (i.e. time of day) by so-called zeitgebers (i.e. 
light). Circadian rhythms are present at molecular, cellular, systems and behavioural levels.  
Molecular and cellular rhythms are found in nearly all cells and tissues in mammals (Buijs, 
Scheer et al. 2006; Kalsbeek, Palm et al. 2006; Maywood, O'Neill et al. 2006). There is 
almost no physiological or behavioural parameter that does not show circadian oscillations. 
Most physiological and behavioural parameters in humans, such as core body temperature 
(CBT), hormone levels (melatonin and cortisol), cognitive performance, subjective sleepiness 
and alertness and the sleep-wake rhythm, to mention only a few, undergo circadian rhythms 
with an approximate 24-h periodicity. The circadian process of C becomes evident under free-
run conditions when external zeitgeber are absent (Aschoff 1965) (Webb and Agnew 1975). 
The circadian process is controlled by a concrete brain region, the first such pacemaker to be 
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identified was the suprachiasmatic nuclei (SCN) located in the anterior hypothalamus. How 
exactly process C exerts its influence on process S is still unresolved. The entrainment 
pathway of the circadian timing system was shown to be a direct projection from the retina to 
the SCN via the retinohypothalamic tract (Hendrickson, Wagoner et al. 1972; Moore and 
Lenn 1972; Moore 1973) and ends as output of the sleep-wake cycle, motor activity, mood, 
behaviour, hormonal secretion and neurobehavioral performance illustrated in Figure 1.2.  
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Figure 1.2: Schematic representation of the circadian system. The central pacemaker in the suprachiasmatic 
nuclei (SCN) receives light directly through retinohypothalamic tract (RHT). Peripheral clocks are coordinated 
by the SCN and are synchronized by specific zeitgeber (i.e. food, activity) (Wirz-Justice unpublished figure). 
 
 
The characteristic of these rhythms may be significantly altered by the environment. This 
effect of exogenous and/or internal influences that modify the circadian rhythmicity 
independent of the biological clock is called masking. 
There is growing evidence that genetic changes (Franken, Chollet et al. 2001; Retey, Adam et 
al. 2005) are also involved. In humans, genetic analysis has shown that clock gene variations 
are involved in the development of certain types of circadian rhythm sleep disorders, such as 
the advanced and delayed sleep phase syndrome (Pace-Schott and Hobson 2002; Ebisawa 
2007). 
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Sleep structure has been shown to exhibit circadian regulation (Dijk and Czeisler 1995). The 
timing of REM sleep is strongly linked to the circadian rhythm, closely mirroring the core 
temperature. Thus, the maximum propensity for REM sleep is usually after the nadir of core 
temperature and it is less likely to occur during an afternoon and evening nap (Borbely 1982) 
(Dijk and Czeisler 1995). Furthermore, wakefulness during sleep or sleep continuity also 
depends strongly on the circadian pacemaker (Dijk and Czeisler 1995), such that sleeping 
outside the biological night (i.e. time of active melatonin secretion) results in an average sleep 
efficiency of only 70% outside the “melatonin window”, compared to 95% within the 
“melatonin window” in normal healthy sleepers. Furthermore, wakefulness depends upon the 
maintenance of an activated cerebral cortex, which is accomplished through two mechanisms: 
input from multiple activating systems with critical input arising from the ARAS and, as we 
will note in a subsequent section, the opposition of homeostatic sleep drive by circadian drive 
for arousal (Moore 2007). 
 
Interaction of homeostatic and circadian processes  
These two distinct processes (homeostatic and circadian) interact to promote the onset of 
sleep when both are high (at the usual bedtime), and maintain sleep when process C is high 
and while process S is declining (in the early hours of morning). The so-called process S 
offsets deviations of sleep by augmenting sleep propensity when the duration of sleep has 
been curtailed, and by reducing sleep propensity in response to excessive sleep. Process C is 
considered to represent a wake-promoting drive to balance the homeostatic accumulation of 
sleep pressure illustrated in Figure 1.3.  
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Figure 1.3: Schematic figure of the “opposing processes” mediating physiological sleepiness as a function of 
time of day. Sleep load increases in response to wakefulness imposed and/or maintained by the pacemaker in the 
SCN. Increasing levels of SCN-dependent alerting signals over the subjective day opposes homeostatic sleep 
drive, both of which peak shortly before the habitual sleep phase. Redrawn with permission from Edgar DM, 
Dement WC, Fuller CA. Effect of SCN lesions on sleep in squirrel monkeys: evidence for opponent processes in 
sleep–wake regulation. (Edgar, Dement et al. 1993) 
 
 
Process S and Process C and their interaction on selected physiological 
and neurobehavioral parameters  
Much behaviour, like subjective mood, shows an underlying circadian rhythm modulated by 
the duration of prior wakefulness (Boivin, Czeisler et al. 1997) illustrated in Figure 1.4. 
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Figure 1.4: Circadian and wake-dependent variations of mood and educed waveform of core body temperature. 
Data from a forced desyncrony study. Mean±SEM values are plotted against circadian phase (left) or time since 
waking (right). W indicates wake, S asleep (Boivin, Czeisler et al. 1997). 
 
The hormone melatonin serves as a chemical messenger of darkness in all species studied to 
date, including birds, fish, reptiles, insects, and mammals, and is an important component of 
the timing systems for circadian, and possibly infradian rhythms (Cassone and Natesan 1997). 
As such, the pattern of secretion of this chemical signal of darkness helps to induce night time 
behaviours. Melatonin also plays an important role in the modulation of circadian rhythms. 
Daily rhythmicity of melatonin secretion has been documented in different vertebrates and 
also in humans e.g. (Voultsios, Kennaway et al. 1997; Wright, Hughes et al. 2001). Melatonin 
does not depend on external stimuli (called zeitgeber) and persists in its absence; therefore the 
circadian rhythm of melatonin is not a result of masking.  
Cortisol is a hormone secreted by the cortex of the adrenal gland. It plays an important role in 
the metabolism of glucose and proteins and has anti-inflammatory properties. Unlike the 
secretion of melatonin, the secretion of cortisol is not suppressed by photic stimulation; it is 
affected by various internal and external factors, the best known of which is stress. In humans, 
circadian rhythmicity in cortisol secretion has been documented by (Leproult, Van Reeth et al. 
1997; van Eekelen, Kerkhof et al. 2003).  
Subjective Sleepiness may be deemed as a physiological state or urge, that promotes the 
onset of sleep, and that is reversed or satiated by attainment of adequate sleep. The neuronal 
substrates of sleepiness are not understood completely. Sleepiness may reflect the waning of 
processes maintaining wakefulness or it may result from distinct neuronal systems acting to 
promote sleep (McCarley 2007). There exist different definitions of sleepiness, which is 
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sometimes confused with fatigue, which is a very well known symptom of depression. 
Subjective sleepiness characterizes a need for sleep and is associated with an elevated 
disposition of falling asleep, usually known to disappear in stressful situations. Sleep 
propensity is often used as a synonym of sleepiness (Carskadon and Dement 1982; Johns 
1998). Fatigue is more a subjective sensation of feeling tired especially in psychic, cognitive 
and somatic requirements.  
Cognitive performance capability at any point in time is largely dependent on the two 
interacting homeostatic and circadian process systems, modulated by both C and S processes. 
The interaction of the two processes generates a constant vigilance performance throughout 
the entire day with 16-h duration. This opponent process is illustrated in figure 1.3. The 
homeostatic drive for sleep escalates with increasing time awake. The circadian system 
produces oscillations in functioning, which have an approximate frequency of one cycle every 
24 hours; there does not exist an adequate theory to describe the underlying brain mechanisms 
responsible for these neurobehavioral deficits. With increasing time awake, particularly 
beyond the habitual amount of time spent awake, performance degrades considerably. 
Interestingly, to recover optimally from sleep loss-related performance decrements, less sleep 
is actually needed than the absolute hours of sleep formerly lost (Bonnet 2000). The circadian 
modulation of cognitive performance indicates a close temporal association with the circadian 
rhythm core body temperature with its maximum in the evening and nadir in the early 
morning (Rogers, Dorrian et al. 2003). 
 
Chronobiology and depression – is there a link? 
The concept of depression as a disease goes back a long way. In earlier times, depression was 
described as melancholia by many famous physicians. During the last century, psychiatric 
classification has been characterized by an inflation of diagnostic categories, including 
numerous subtypes of depression (see the numerous DSM and ICD classification systems). 
Severity, duration and recurrence are used as bases for classification. In terms of 
classification, depressive disorders, including the sub-classifications have long been 
recognized as heterogeneous. The core symptoms of MDD, of which at least one is required 
in DSM-IV, are depressed mood and loss of interest or pleasure. Further eligible symptoms 
are significant weight loss or gain, insomnia or hypersomnia, psychomotor agitation or 
retardation, fatigue or loss of energy, feelings of worthlessness or excessive or inappropriate 
guilt, diminished ability to think or concentrate, or indecisiveness, recurrent thoughts of death, 
recurrent suicidal ideation without a specific plan, suicide attempt or a specific plan for 
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committing suicide. These symptoms have to occur almost daily during the same two week 
period within the most recent four week period, and represent a change from previous 
functioning of the person. 
These core symptoms reflect the view that the depressive disorder is essentially a disorder of 
mood or affect and belongs as a subgroup to the mood respective affective disorders. 
Depression is a heterogeneous syndrome rather than a single disease, and has been 
characterized as a collection of “physiological, neuroencocrine, behavioural and 
psychological symptoms“ (Nestler, Barrot et al. 2002; Fuchs, Simon et al. 2006). 
According to the World Health Organization, depression affects nearly 121 million people 
worldwide. It is also one of the top 10 causes of morbidity and mortality (Rosenzweig-Lipson, 
Beyer et al. 2007).  
Depression is a very complex disease and many gaps remain in our understanding of the 
aetiology and pathophysiology of depression. However, an increasing amount of evidence is 
now pointing to the possibility that chronobiological difficulties may underlie or at least 
accompany the condition. Numerous studies undertaken in depressive patients have suggested 
that a common comorbidity of depression is the dysregulation of the circadian timing system. 
This seems to occur in various types of depression, but is particularly evident in bipolar 
disorder (Bunney, Murphy et al. 1970; Wehr and Goodwin 1981). A particular feature of 
MDD is the abnormality in the timing and distribution of rapid eye movement (REM) and 
NREM sleep stages that can be regarded as a primary characteristic of the disease (Armitage 
2007). Studies of sleep in depressive and affective disorders have been useful in supporting 
theoretical considerations about their pathophysiology (Srinivasan, Smits et al. 2006).  
As we know from different contexts, most depressed suffer from insomnia. Paradoxically, it is 
hypothesized that according to the two process models of sleep regulation, SD may ameliorate 
the disease pattern, especially improving mood. Borbély and Wirz-Justice (Borbely and Wirz-
Justice 1982) consider in their sleep regulation model that the depressed show a deficit in 
process S, which could manifest itself in slower build-up of sleep pressure during wakefulness 
or a different rate of decline during sleep (Figure 1.5 right). Hence, a full night of SD would 
raise it nearer to the normal values (Figure 1.5 right, dotted line). SD is conducive as a rapid 
and effective short-term treatment for depression (Wirz-Justice and Van den Hoofdakker 
1999) (Giedke, Wormstall et al. 1990).  A deficit in process C could be manifested in changed 
amplitude, phase or endogenous period (Figure 1.5 left). A shift in phase relationship between 
C and S can cause decrements in mood (Wirz-Justice 1995; Wirz-Justice 2003; Wirz-Justice 
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2006). In this context it has to be mentioned that it is thought that light therapy works by 
shifting the circadian rhythm (Wirz-Justice, Benedetti et al. 2005). 
From pharmaceutical studies we have evidence that functional alterations in brainstem 
noradrenergic or serotonergic systems regulate mood and affective behaviours and the sleep-
wake cycle. Imaging studies (Drevets 2001; Mayberg 2003) have since shown that several 
brain areas such as the prefrontal cortex, cingulated cortex, hippocampus, striatum, amygdale 
and thalamus are active during the experience of sleep disorders (insomnia and fatigue) as 
well as during disorders of mood (including depressed mood, feelings of worthlessness, 
diminished ability to concentrate, recurrent thoughts of death or suicide, as well as other 
symptoms as per the DSM-IV criteria for depressive disorders (American Psychiatric 
Association, 1994) (Association 1994)). Other studies have shown that an increased incidence 
of depressive symptoms correlates with poor sleep quality or chronic insomnia; disturbances 
that appear to be major risk factors for depression (Lustberg and Reynolds 2000).  
 
  
Figure 1.5: Schematic representation of the two-process models of sleep regulation. Left illustration shows the 
circadian process “C” which follows a 24-h rhythm independent of duration of prior wakefulness. In depression, 
it has been hypothesized that the circadian system might have an altered endogenous periodicity, advanced or 
delayed phase, and/or diminished amplitude. Additionally, the phase relationship between circadian and 
homeostatic processes could be abnormal. The illustration on the right depicts the homeostatic Process “S”, 
which builds up exponentially during time awake and declines exponentially during sleep. The dotted line 
symbolises a putative disturbance in depression with a lower build up rate that only attains normality after 40-h 
of total SD (Wirz-Justice 2006).  
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Objectives and Methods 
An important factor in circadian research is the so-called “masking” influence. Any external 
(e.g. light, body posture, food intake) or internal factor (e.g. stress level, motivation) has the 
potential to mask the “true” endogenous circadian rhythm. Therefore, these masking effects 
have to be controlled for. The constant routine protocol (CR) is a setting that realises 
minimalized and constant adherence of all known relevant masking factors. The CR is the 
gold standard to distinguish endogenous from exogenous drives of circadian rhythmicity. 
Study participants are kept under constant dim light levels, in semi-recumbent posture in bed, 
with isocaloric food and liquid intake spread over 24-h at regular intervals, and no time cues 
(Mills, Minors et al. 1978; Czeisler, Allan et al. 1986). The CR protocol in this thesis 
comprised 40-h of sustained wakefulness (the high sleep pressure protocol) and was 
contrasted against a 40-h period under CR conditions of sleep satiation realised by ten 
ultradian cycles of 225 minutes (150 min of scheduled wakefulness and 75 min of scheduled 
sleep; low sleep pressure protocol or nap protocol) demonstrated in figure 1.6. A limitation of 
the CR protocol is that there is no desynchronization between the sleep-wake cycle and the 
circadian pacemaker. Therefore, it does not allow for a segregation of these two processes. 
Nonetheless, investigation of the contribution of sleep pressure remains possible to some 
extent by comparing one condition in which subjects are totally sleep deprived during the 
entire experiment (high sleep pressure) to another condition in which they are allowed to nap 
regularly, the latter keeping homeostatic sleep pressure at a low level (low sleep pressure 
condition). Another very demanding protocol is the forced desynchrony protocol, which 
effectively uncouples the sleep-wake cycle and the endogenous circadian cycle. Both 
experimental paradigms expose the interaction of the homeostatic and circadian processes 
regulating sleep and wakefulness. 
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Figure 1.6: Schematic representation of the two 3.5-day protocols for high (left side) and low (right side) sleep 
pressure condition. White areas indicate scheduled wakefulness and dark bars delineate the scheduled sleep 
episodes. Hatched bars depict constant posture, semi-recumbent during wakefulness and recumbent during sleep 
(without baseline week and adaptation night).  BL=baseline night, REC=recovery night. 
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Outline of the thesis 
The project on which the present thesis emerges tested the hypothesis whether major 
depression is a “clock”- or sleep disturbance or a “masking”-problem. In particular, the 
relative contributions of circadian and sleep homeostatic processes are investigated by 
carefully controlled protocols designed to minimize masking. Thus the following thesis aimed 
at elucidating the influence of the circadian system and the sleep–wake homeostat on mood, 
sleepiness, psychomotor vigilance performance, melatonin and the EEG during wakefulness 
in young women suffering from MDD in comparison to healthy age-matched women. Eight 
young women (24±4.8y) with MDD spent four days in the chronobiological facility at the 
Psychiatric University Clinics Basel and undertook the CR protocol during 40-h of sustained 
wakefulness or 40-h nap protocol attained with multiple naps. Depressed subjects selected for 
this study fulfilled the DSM-IV-TR diagnostic criteria for MDD without co-morbidity of 
another DSM-IV-TR disorder (axis I) and were in a major depressive episode undergoing the 
protocol. Equally, we have excluded depressed women with a high score (≥8) in the 
Pittsburgh sleep quality index (PSQI) (Buysse, Reynolds et al. 1989). 
Subjective well-being, subjective sleepiness, melatonin and cortisol levels were first 
compared between two different age and gender groups of healthy participants under 
unmasked conditions in a high (i.e. SD) and low (i.e. Nap protocol) sleep pressure protocol of 
64-h. These data served as the basic model to quantify circadian and sleep-wake related 
changes in subjective variables in healthy volunteers (Chapter 2). Before attempting to 
understand psychopathology it is important to consider normal daily variations of mood. The 
time course of subjective well being under constant routine conditions shows a circadian 
rhythm under low and high sleep pressure conditions (allegorized in Chapter 2).  
In Chapter 3, the S-deficiency hypothesis of depression is tested by analysing waking EEG 
activity (an objective measure of sleepiness) and comparing the results against subjective 
sleepiness and tension during sustained wakefulness, using melatonin as the circadian marker 
of internal time. In Chapter 4, the focus is diurnal variations of mood and whether SD has an 
antidepressant effect. In the final Chapter 5, the time course of alertness in the depressive 
cohort as measured by a psychomotor vigilance performance test is investigated. Chapter 6 
concludes by discussing the general implications of the findings for understanding putative 
circadian rhythm and sleep disturbances in depression, which may explain the efficacy of 
non-pharmalogical chronotherapeutics such as light therapy and SD.  
In chapter 3, 4 and 5, data gathered from the same 64-h high and low-sleep pressure protocol 
from MDD patients are reported. The hypothesis that depression could be linked to a 
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deficiency in the sleep-wake homeostatic process (i.e. the so-called S-deficiency hypothesis) 
was tested by waking EEG recordings during sustained wakefulness along with assessment of 
subjective sleepiness, tension and salivary melatonin (Chapter 3). Chapter 4 focussed on the 
investigation of diurnal variations in mood ratings and the well known antidepressant effect of 
SD in our cohort of MDD women. In a final step, in Chapter 5, psychomotor vigilance 
performance was analysed in MDD women under high and low sleep pressure conditions and 
compared against the healthy women. The general implications of these findings for 
understanding putative circadian rhythm disturbances in depression and the possibilities for 
forming a basis for the development of new treatment strategies such as light therapy and 
administration of chronotherapeutics (i.e. SD) are discussed in chapter 6.  
 
Aims and hypotheses of the studies   
The aim of this thesis was to investigate the influence of homeostatic and circadian processes 
in young depressive women by using the constant routine protocol under two differential 
sleep pressure conditions. 
The specific goals in this project (Chapter 2-5) were: 
 
A. To investigate how subjective well-being, subjective sleepiness, salivary 
melatonin and salivary cortisol are modulated under two different sleep pressure 
conditions in healthy subjects, and to test if there are age and gender-related differences. 
 Working Hypotheses: We expected that… 
1. Subjective well-being is worse under high (SD) than under low sleep pressure  
 conditions (nap protocol). 
2. The circadian modulation of subjective well-being is more apparent in young than  
 older study participants. 
3. Women exhibit a more pronounced circadian modulation in subjective well-being than  
 men. 
4. Older study participants show lower subjective well-being ratings than young,  
 particularly under high sleep pressure conditions. 
5. The circadian modulation of subjective well-being exhibits a temporal correlation with  
 other variables such as subjective sleepiness, cortisol, and the major circadian marker  
 melatonin. 
 
  21 
B. To find out whether the very often proclaimed hypothesis of a deficiency in 
the homeostatic process of the sleep-wake regulation and diminished amplitude in 
circadian parameters, such as melatonin in depression, is verified, as well as a reduced 
response in frontal brain regions under sleep deprivation. And whether there is a 
correlation between subjective sleepiness and objective sleepiness measured by waking 
EEG.  
Working Hypotheses: We expected that… 
1. Depressed women experience a deregulation of sleep-wake homeostasis in comparison  
to healthy women, as indexed by an altered time course in frontal low-EEG activity (1-
7 Hz) during 40-h of sustained wakefulness.  
2. Based on the deregulation of sleep-wake homeostasis, depressed women experience  
 higher subjective sleepiness during 40-h of sustained wakefulness.  
3. Depressed women show a diminished amplitude and/or circadian phase delay in  
 salivary melatonin secretion under high sleep pressure conditions. 
 
C. To affirm that sleep deprivation (high sleep pressure condition) improves 
mood in Major Depressive Disorder 
 Working Hypotheses: We expected that… 
1. Depressive patients exhibit an improvement in subjective mood under high sleep  
 pressure conditions compared to controls. 
2. Under low sleep pressure, subjective mood displays a more circadian modulation than  
 under high sleep pressure particularly in depressive women. 
 
D. To investigate what role psychomotor vigilance plays in young women with 
major depression under different sleep pressure conditions? Does sleepiness differ from 
alertness? Are these antonyms? Does neurobehavioral performance demonstrate 
performance enhancement under the influence of the antidepressive effect of mood?  
Working Hypotheses: We expected that… 
1. Depressed women show worse psychomotor vigilance performance than controls.  
 However, this difference is negligible with accumulating sleep pressure in the high
  sleep pressure protocol, due to the higher “prefrontal tiredness”. 
2. Psychomotor vigilance performance under low sleep pressure will be constantly  
 reduced in depressed women compared to controls. 
3. The improvement in psychomotor vigilance performance during high sleep pressure  
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 conditions in depressed women correlates with the antidepressant effect of SD. 
4. Depressed women will undergo inferior physical comfort than healthy controls during  
 the PVT performance under high sleep pressure conditions. 
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ABSTRACT 
Subjective well-being largely depends on mood, which shows circadian rhythmicity and can 
be linked to rhythms in many physiological circadian markers, such as melatonin and cortisol. 
In healthy young volunteers mood is influenced by an interaction of circadian phase and the 
duration of time awake. We analyzed this interaction under differential sleep pressure 
conditions in order to investigate age- and gender effects on subjective well-being. Sixteen 
healthy young (8 women, 8 men; 20-35 years) and 16 older volunteers (8 women, 8 men; 55-
75 years) underwent a 40-h sleep deprivation (high sleep pressure) and a 40-h nap protocol 
(low sleep pressure) in a balanced cross-over design under constant routine conditions. Mood, 
tension and physical comfort were assessed by visual analogue scales during scheduled 
wakefulness, and averaged formed a composite score of well-being. Significant variations in 
well-being were determined by the factors “age”, “sleep pressure” and “circadian phase”. 
Well-being was generally worse under high than low sleep pressure. Older volunteers felt 
significantly worse than the young under both experimental conditions. Significant 
interactions were found between “sleep pressure” and “age”, and between “sleep pressure” 
and “gender”. This indicated that older volunteers and women responded with a greater 
impairment in well-being under high compared to low sleep pressure. The time course of 
well-being displayed a significant circadian modulation, particularly in women under high 
sleep pressure conditions. Our results demonstrate age- and/or gender-related modifications of 
well-being related to sleep deprivation and circadian phase and thus point to specific 
biological components of mood vulnerability. 
 
Keywords: Mood, constant routine, sleep deprivation, sleepiness, melatonin, cortisol, sleep-
wake homeostat, circadian rhythm 
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INTRODUCTION 
Circadian and homeostatic influences 
Subjective well-being largely depends on current mood, which is determined by both 
psychological and physical state. Under controlled laboratory conditions, subjective mood, 
assessed by a visual analogue scale (VAS), exhibits circadian rhythmicity (Boivin, Czeisler et 
al. 1997; Koorengevel, Beersma et al. 2003) similar to that of subjective sleepiness and 
cognitive performance (Van Dongen and Dinges 2005) and can be linked to rhythms in many 
physiological circadian markers such as core body temperature, heart rate, or the hormones 
melatonin and cortisol. In addition to the circadian component, manipulations of the sleep-
wake cycle also have a strong impact on mood regulation such that subjective mood 
dramatically changed by altering the duration and timing of sleep episodes, thus suggesting 
that the duration of sleep and its position in the circadian cycle is critical for mood regulation 
(Taub and Berger 1973; Taub and Berger 1974; Monk, Buysse et al. 1992; Wood and 
Magnello 1992). Lack of sleep per se leads to mood deterioration in healthy subjects 
(Brendel, Reynolds et al. 1990; Scott, McNaughton et al. 2006) to such an extent that the 
timing of sleep, in sleep displacement studies, can significantly impact daily mean values of 
mood (Totterdell, Reynolds et al. 1994). Taken together, both circadian phase and the amount 
of prior wakefulness play a key role in the regulation of subjective mood.  
 
Quantification of the differential influence of these two important factors in a forced 
desynchrony study design has revealed that subjective mood is modulated by a complex and 
non-additive interaction of circadian phase and duration of prior wakefulness (Boivin, 
Czeisler et al. 1997). The nature of this interaction was such that even moderate changes in 
the timing of the sleep-wake cycle led to profound effects on mood (Boivin, Czeisler et al. 
1997). Similarly, after advancing the sleep-wake cycle daily by 20 min for a week, mood 
ratings fell strongly during the biological night compared with the stable sleep control group 
(Danilenko, Cajochen et al. 2003). 
 
The Profile of Mood States questionnaire (POMS) (McNair, Lorr et al. 1971), a self-report 
inventory, is commonly used for measuring distinct mood states. Another frequently used 
instrument is the PANAS that measures two broad dimensions of Positive Affect (PA) and 
Negative Affect (NA) (Watson and Clark 1997). NA did not exhibit a clear circadian 
component whereas PA did and its 24-hour rhythm correlated with the circadian rhythm of 
rectal temperature (Murray, Allen et al. 2002). Affective state, as measured by various mood 
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and subjective activation scales (e.g. (Covi, Lipman et al. 1977; Monk 1989)), is also sensitive 
to sleep loss (Reynolds, Kupfer et al. 1986; Bonnet 1989). Another interesting aspect is that 
the characteristics of morningness (M) or eveningness (E) in healthy subjects significantly 
impact on their mood states (measured by POMS): E chronotypes improved mood and 
decreased anger-hostility after partial and total sleep deprivation, and activity was decreased 
after total sleep deprivation. For M chronotypes partial sleep deprivation did not modify 
mood, whereas total sleep deprivation worsened depressive mood and tiredness, and 
decreased vigor-activity (Selvi, Gulec et al. 2007).   
 
Age and gender related influences 
Younger subjects consistently rated themselves lower on global measures of vigour and affect 
than older subjects, with a sharper decrease of vigour on the day following sleep deprivation 
(Brendel, Reynolds et al. 1990). This suggests that acute sleep deprivation may actually be 
more disruptive for younger than for older adults, who may have greater mood stability and 
less rhythmic changes (Monk, Buysse et al. 1992). However another study under 36-h bed rest 
conditions revealed no differences in temporal profiles between older and young volunteers 
(Buysse, Monk et al. 1993).  
No significant gender effect on mood was found in a study with pilots (Caldwell and LeDuc 
1998), although another study showed that the diurnal rhythm of mood in women peaked 2 
hours earlier than men (Adan and Sanchez-Turet 2001). However, to our knowledge there are 
no studies on age and gender-related differences in circadian and homeostatic mood 
regulation so far. 
 
Study aim 
We investigated the time course of subjective mood, tension and physical comfort ratings in 
young and older healthy subjects under differential sleep pressure conditions in order to 
quantify circadian and homeostatic contributions to these ratings. Because the 40-hour 
protocol assesses subjective well-being at a high sampling frequency (in addition to collecting 
physiological variables and carrying out performance and memory tests), we could not 
implement a large questionnaire battery, but selected the previously validated, readily 
comprehensible and fast VAS technique to maintain subjects’ motivation. A significant 
concern in the present study was that physical discomfort and tension arising in the course of 
the demanding protocol (64 hours of bed rest) may impact subjective mood ratings, 
particularly in the older cohort. Thus, we decided to combine tension and physical comfort 
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together with subjective mood into a composite score and defined this score as an index of 
subjective well-being. 
 
We utilised a very strictly controlled constant routine protocol to minimise the majority of 
confounding (“masking”) factors [for details see (Cajochen, Knoblauch et al. 2001)].  
Based on the fact that more women than men suffer from mood disorders and older subjects 
experience more physical problems and reduced circadian modulation than young that will 
manifest itself particularly under high sleep pressure conditions we predicted that: 
1. Subjective well-being is worse under high (sleep deprivation) than under low sleep  
pressure conditions (nap protocol). 
2. The circadian modulation of subjective well-being is more apparent in young than  
 older study participants. 
3. Women exhibit a more pronounced circadian modulation in subjective-well being than  
 men. 
4. Older study participants show lower subjective well-being ratings than young,  
 particularly under high sleep pressure conditions. 
5. The circadian modulation of subjective well-being exhibits a temporal correlation with  
other variables such as subjective sleepiness, cortisol and the major circadian marker 
melatonin. 
 
METHODS 
Study participants  
All study participants were recruited via advertisements at different Swiss universities and in 
newspapers. Sixteen healthy young (8 women and 8 men, age range 20-31y, mean age 
25.0±3.3y [SD]) and 16 healthy older volunteers (8 women and 8 men age range 57-74y, 
mean age 65.0±5.5y) were selected. The mean body mass index (BMI) was 21.5±1.6 [SD] for 
the young and 23.3±2.1 for the older volunteers (t-test: p < 0.05). Each study volunteer 
underwent a physical examination, an interview about sleep quality, life habits and health 
state, a neuropsychological test battery [CANTAB® test battery and the Stroop Test (only for 
the older group)]. All were free of medical, psychiatric, neurological and sleep disorders [as 
per Pittsburgh Sleep Quality Index (PSQI) score ≤5 (Buysse, Monk et al. 1993), and a 
polysomnographically (PSG) recorded screening night]. The mean PSQI value was 2.1±1.3 
[SD] for the young and 3.4±1.7 S.D. (t-test: p < 0.05) for the older volunteers. Volunteers 
were included if their clinical sleep EEG scoring had no pathological findings 
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[apnoea/hypopnoea-index (AHI) <10/h; periodic leg movements (PLM) index <10/h]. To 
exclude chronotype-specific differences in circadian phase preference we selected only 
moderate chronotypes (morning-evening-type [M/E] Questionnaire rating between 14 and 21 
points) (Torsvall and Åkerstedt 1980). Nevertheless, M/E scores were slightly higher in the 
older than in the younger group (mean±SEM: 18.8±0.8 vs. 16.4±0.8; t test: p<0.05), 
corresponding to an earlier chronotype. All participants were non-smokers without any drug 
abuse. This was verified in the young group by urinary toxicological analysis, sensitive for 
amphetamines, benzodiazepines, opiates and tetrahydrocannabinol (Drug-Screen Card Multi- 
6®, von Minden GmbH, Moers, Germany). Participants were also required to abstain from 
excessive caffeine and alcohol consumption as well as heavy physical exercise. Other 
exclusion criteria were: shift work within 3 months and transmeridian flights within 1 month 
prior to the study, excessive caffeine and alcohol. The young women started the study on days 
1–5 after menses onset in order to complete the entire study block within the follicular phase, 
with the exception of five young women taking oral contraceptives.  
All procedures conformed to the Declaration of Helsinki. The local Ethical Committee 
approved the study protocol, screening questionnaires and consent form [for details see 
(Munch, Knoblauch et al. 2004; Munch, Knoblauch et al. 2007)] and all study participants 
gave signed informed consent. 
 
Protocol and study design 
Each participant was instructed to maintain a regular sleep–wake cycle (bed- and wake-times 
within ±30 min of self-selected target time), which was verified by wrist activity monitors 
(Cambridge Neurotechnology®, UK) and sleep logs during one week prior to study begin. 
Habitual bedtimes did not vary significantly between groups (young: 23:34±56 min vs. older: 
23:11±40 min; mean±SD; p=0.2, t-test). The study entailed a balanced and gender-matched 
cross-over design, each block lasting 3.5 days (details in  Figure 2.1), and started with an 8-h 
PSG night in the laboratory. During day 1 subjects adjusted to the experimental dim light 
condition (<8 lux), and a morning a blood sample was taken from the older participants to 
verify both a normal haemogram and physiological coagulation; they received a low-dose 
heparin injection on the three consecutive days of each study block (Fragmin® 0.2 ml, 2500 
IE/Ul, Pharmacia AG, Dübendorf, Switzerland) in order to prevent any venous thrombosis. 
After a second 8-h sleep episode, all subjects participated in a 40-h “constant routine” (CR) 
protocol as detailed in (Cajochen, Knoblauch et al. 2001; Munch, Knoblauch et al. 2004; 
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Knoblauch, Munch et al. 2005; Munch, Knoblauch et al. 2007), which was followed by a 
recovery night. 
The subjects underwent two CR conditions spaced 1-3 weeks apart: a high sleep pressure [40-
h sleep deprivation (SD) protocol] and a low sleep pressure (10 cycles of 150 min scheduled 
wake: 75 min scheduled sleep; NAP protocol). The 8-h sleep episode was calculated with 
respect to the midpoint of each individual’s habitual sleep episode as assessed by actigraphy 
and sleep logs during the baseline week. All wake episodes were spent under semi-recumbent 
CR conditions (<8 lux) during wakefulness with a minor shift to supine posture during 
scheduled sleep episodes (0 lux).  
Time of Day
Day 1
Day 2
Day 3
24 8 2416
BL 1
REC
Day 4
BL 2
Time of Day
Day 1
Day 2
Day 3
24 8 2416
BL 1
REC
Day 4
BL 2
Sleep (0 lux) Wake (8 lux) In Bed
High sleep pressure (SD) Low sleep pressure 
(NAP)
 
Figure 2.1: Overview of the 3.5-day laboratory protocol (without baseline week and adaptation night). Black 
bars (0 lux) indicate scheduled sleep episodes and white bars scheduled wake episodes (<8lux). Grey bars 
denote controlled posture (semi-recumbent during wakefulness and supine during sleep). BL=baseline night, 
REC=recovery night. The data analysed in this paper were gathered in the 40 hours between baseline night 2 
and the recovery night, which was a constant routine protocol with either total sleep deprivation or multiple 
naps.   
 
Subjective rating scales 
Subjective well-being was a composite score averaged over the three items “mood, tension, 
and physical comfort”, each assessed by a 100-mm bipolar VAS at 30-min intervals. The 
participants were asked to indicate how he or she felt “at that moment” by placing a vertical 
mark on the VAS ranging from 0 (“worst ever”) to 100 mm (“best ever”). Since the direction 
of the extremes was not the same for all the three items the formula was as follows: subjective 
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well-being = [VASmood+ (100-VAStension) + VASphysical comfort]/3. In addition, VAS estimates of 
alertness, hunger, and subjective thermal comfort were collected. Although the reliability and 
validity of VAS especially in measuring emotions have been confirmed in many studies 
(Aitken 1969); (Folstein and Luria 1973), our index of subjective well-being has not yet been 
validated. However, we have first evidence from an ongoing constant routine study in our 
laboratory that the dimension of positive affects in the PANAS correlate rather well with the 
composite score of subjective well-being (r=0.66, p<0.025) and even more so for the specific 
items VASmood  and the item happiness on the PANAS (r=0.74 ; p<0.01). 
Subjective sleepiness was assessed by the composite score of the Karolinska Sleepiness Scale 
(KSS) and the Karolinska Sleepiness Symptoms Check List (KSSCL) at 30-min intervals. 
 
Salivary assays 
Saliva collections for hormonal assays were scheduled during wakefulness at the same 30 min 
time intervals as subjective ratings.  
Melatonin: a direct double-antibody radioimmunoassay (RIA) was used for the melatonin 
assay (validated by gas chromatography–mass spectroscopy with an analytical least detectable 
dose of 0.65 pm/ml); Bühlmann Laboratories, Schönenbuch, Switzerland (Weber, JC et al. 
1997).  
For mean melatonin levels, values of all samples between the upward- and downward-mean 
crossing points were averaged per subject and age group. A nap was classified as occuring 
during the biological night if the melatonin concentration of the last saliva sample prior to the 
nap was above the individual mean, otherwise it was classified as a nap during the biological 
day (Knoblauch, Munch et al. 2005; Munch, Knoblauch et al. 2005). 
Cortisol: Cortisol was measured by RIA (Ciba Corning Diagnostics) with a detection limit of 
0.2 nmol/l. The intra-assay CV was 4.0% above 0.4 nmol/l and 10.0% for levels below. 
 
Data analyses and statistics 
For data reduction, all values were collapsed into 3.75-h bins per subject before averaging 
over subjects. For all analyses, the statistical packages SAS® (SAS Institute Inc., Cary, NC, 
USA; Version 6.12) and Statistica® (Stat-Soft Inc., 2000–2004, STATISTICA for Windows, 
and Tulsa, OK, USA) were used. Four-way repeated measures ANOVA (rANOVA) with the 
factors ‘age’ (young vs. older), ‘gender’ (women vs. men), and the repeated factors ’sleep 
pressure’ (high vs. low sleep pressure condition) and ‘time of day’ (11 time points) were 
performed. All p-values derived from rANOVAs were based on Huynh-Feldt’s (H-F) 
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corrected degrees of freedom (significance level: p <0.05). At some time points the data for 
different variables (e.g. subjective well-being, melatonin etc.) were not normally distributed, 
and thus a non-parametric test was used for post-hoc comparisons (Mann-Whitney U test). 
Backward stepwise regression analysis was performed to identify the important predictor 
variables among subjective sleepiness, cortisol and melatonin for subjective well-being. 
 
RESULTS 
Subjective well-being  
Mean subjective well-being ratings in the course of the high (SD) and low sleep pressure 
(NAP) protocol for the young and older women and men are illustrated in Figures 2.2 and 2.3. 
In general, all participants assessed their subjective well-being as better than average with an 
initial score above 50 (0= worst ever and 100= best ever). The rANOVA yielded significance 
for the main factors ‘age’, ‘sleep pressure’ and ‘time of day’ (Table 1). Average well-being 
was significantly lower in older participants than the young (56.9±2.2 vs. 65.3±2.1), and 
lower during SD than NAP conditions (59.7±1.9 vs. 62.4±1.6). A circadian modulation 
revealed lower ratings during the biological night compared to the biological day. Well-being 
of older participants was more impaired under SD conditions than the young (-5.5±2.4 vs. -
0.1±2.2; interaction ‘age x sleep pressure’, Table 2.1). The significant two-way interaction 
‘gender x sleep pressure’ emphasizes a clear decrement in subjective well-being in women but 
not in men under the SD condition (-6.0±2.4 vs. 0.4±2.6). Young men did not seem to be 
affected by rising sleepiness under SD (Figure 2.3), and show a rather flat curve throughout. 
In contrast, subjective well-being declined in both young and older women during the evening 
(significant difference between young women and men between 17:30 and 04:30 h, p at least 
0.04, Mann Whitney U-test). In the NAP protocol we only found a significant time of day 
effect. This protocol has the characteristic of revealing the underlying circadian rhythm since 
sleep pressure does not rise to mask it. 
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Factor Subjective 
Well-being 
Subjective 
Sleepiness 
Melatonin Cortisol 
Age group P=0.012 P=0.048 P=0.03 n.s. 
Gender n.s. P=0.053 n.s. n.s. 
Sleep Pressure P=0.009 P<0.0001 P=0.03 n.s. 
Time of Day P<0.0002 P<0.0001 P<0.0001 P<0.0001 
Age x Gender n.s. n.s. n.s. n.s. 
Age x Sleep Pressure P=0.012 n.s. P=0.0037 n.s. 
Age x Time of Day n.s. n.s. n.s. P=0.03 
Age x Time of Day x Sleep Pressure n.s. n.s. P=0.014 n.s. 
Gender x Sleep Pressure P=0.003 n.s. n.s. n.s. 
Gender x Time of Day n.s. P=0.045 n.s. P=0.001 
Sleep Pressure x Time of Day n.s. P<0.0001 P=0.03 n.s. 
Sleep Pressure x Age x Gender n.s. n.s. n.s. n.s. 
Time of Day x Age x Gender n.s. n.s. n.s. n.s. 
Time of Day x Age x Gender x Sleep Pressure n.s. n.s. n.s. P=0.02 
 
Table 2.1: Main and interaction effects of age, gender, sleep pressure and time-of-day on subjective well-being, 
subjective sleepiness, and salivary melatonin and cortisol levels.  n.s. = non significant (p>0.05). 
 
Subjective sleepiness  
The time course of subjective sleepiness is the second panel in Figures 2.2 and 2.3. The 
rANOVA yielded significance for the main factors ‘age’, ‘sleep pressure’ and ‘time of day’ 
and was at near significance for the factor ‘gender’ (p=0.053; Table 2.1). Older volunteers 
were on average sleepier than the young (4.2±0.3 vs. 3.5±0.2), and all participants were 
sleepier during high than low sleep pressure conditions (4.9±0.3 vs. 2.8±0.1). Significant two-
way interactions were found for ‘gender’ x ‘time of day’ as well as for ‘sleep pressure’ x 
‘time of day’. Women were sleepier than men particularly during the biological night and 
during the SD protocol. Young women were sleepier than young men in the SD protocol from 
12:00 h the first day until 18:45 h the next day (p at least 0.04, Mann Whitney U-test). There 
was a marked circadian modulation of sleepiness in all sleep pressure conditions and age 
groups (previously reported for the nap protocol (Munch, Knoblauch et al. 2005)).  
 
Melatonin  
The time course of salivary melatonin concentration is illustrated in the third panel of figures 
2.2 and 2.3. The rANOVA yielded significance for the main factors ‘age’, ‘sleep pressure’ 
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and ‘time of day’ (Table 1). Older volunteers had significantly lower mean melatonin levels 
than the young (3.8±0.5 vs. 6.4±1.1 pg/ml), and all volunteers had slightly but significantly 
higher melatonin levels during the low (NAP) than the high sleep pressure (SD) protocol 
(5.4±0.7 vs. 4.8±0.6 pg/ml). The significant two-way interaction ‘age’ x ‘sleep pressure’ 
indicated that elevated melatonin levels under low compared to high sleep pressure conditions 
were only seen in the young but not the older volunteers. Furthermore, the significant two-
way interaction ‘sleep pressure’ x ‘time of day’ and a significant three-way interaction ‘age’ x 
‘sleep pressure’ x ‘time of day’ was observed. Post-hoc comparisons revealed significantly 
higher melatonin levels in young women compared to young men between 02:45-06:30 h 
(SD) during high sleep pressure (SD) and 17:00-10:00 h the next day (NAP) (p at least 0.04, 
Mann Whitney U-test). 
Although melatonin secretion was diminished in older volunteers, there were no significant 
differences compared to the young in circadian phase position or timing of the sleep-wake 
cycle, nor did the phase angle between them differ [results published in (Knoblauch, Munch 
et al. 2005; Munch, Knoblauch et al. 2005)]. 
 
Cortisol  
The time course of salivary cortisol concentration is illustrated in the bottom panel of figures 
2.2 and 2.3. Only the main factor ‘time of day’ yielded significance (Table 1). However, the 
four-way interaction (‘age’ x ‘gender’ x ‘sleep pressure’ x ‘time of day’) as well as the two-
way interactions ‘age’ x ‘time of day’ and ‘gender’ x ‘time of day’ were significant. The 
former most likely reflects a reduced circadian profile in cortisol secretion in the older 
subjects. The latter reflects higher cortisol levels in the evening in young women than young 
men between 23:00-6:30 h, and lower cortisol levels from 14:00-17:45 h on the second day (p 
< 0.05 Mann Whitney U-test). 
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Figure 2.2: Time course of subjective well-being in young (left) and older (right) volunteers under low sleep 
pressure conditions (nap protocol; mean values per 3.75-h bin±SEM; n=16). Open circles represent men and 
filled black circles women (Top Panel). The x- axis  above the figure describes time of day (in hours) and the x-
axis below describes elapsed time into protocol (time course over 40 hours). Subjective well-being is expressed 
as the average of three different 100mm visual analogue scales (mood, tension, and physical comfort). Panel 2: 
Time course of subjective sleepiness (composite score of KSS and KSSCL). Panel 3: Time course of salivary 
melatonin concentrations (pg/ml). Bottom Panel: Time course of salivary cortisol secretion (nmol/L). 
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Figure 2.3: Time course of subjective well-being in young (left) and older (right) volunteers under high sleep 
pressure conditions (sleep deprivation protocol; mean values per 3.75-h bin±SEM; n=16) (Top Panel). Details 
as in Figure 2. Panel 2: Time course of subjective sleepiness. Panel 3: Time course of salivary melatonin 
concentrations. Bottom Panel: Time course of salivary cortisol secretion. 
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Subjective sleepiness and cortisol levels as predictors for subjective 
well-being 
In order to investigate possible relationships between subjective well-being, subjective 
sleepiness, and the circadian marker cortisol, a backward stepwise regression analysis was 
calculated (Table 2.2). Subjective well-being showed the highest correlations (r = -0.45) with 
subjective sleepiness followed by cortisol (r = - 0.15), while melatonin was excluded by the 
regression model. Thus, subjective sleepiness can explain in general about 20% of the 
variation in the subjective well-being ratings of our data pool. To further test whether this 
association depended on circadian phase and sleep pressure conditions, subjective well-being 
and sleepiness were correlated at the 11 different time points throughout the high and low 
sleep pressure protocol separately (Figure 2.4). For time points exceeding the usual 16 hours 
of wakefulness, we found a significant correlation between subjective well-being and 
sleepiness. Up to 50 percent of the variation in subjective well-being could be explained by 
subjective sleepiness at times when high sleep pressure coincided with the circadian trough (4 
am). Under low sleep pressure conditions, however, there was never a significant correlation 
observed, despite the evidence for a clear circadian impact on both subjective well-being and 
sleepiness ratings. 
 
Variable df F r P 
Subjects 
Subjective 
sleepiness 
Cortisol 
Residuals 
Total 
31 
 
1 
 
1 
 
690 
 
721 
 
 
180.5 
 
20.2 
 
 
 
 
 
 
-0.45 
 
-0.15 
 
 
 
 
 
 
0.0001 
 
0.0008 
 
 
 
 
 
Table 2.2: Results of the backward stepwise regression analysis. 
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Figure 2.4: Time course of the correlation coefficient (r²) between subjective well-being and subjective 
sleepiness in the course of the high (closed symbols) and low sleep pressure protocol (open symbols). The 
stippled horizontal line delineates the threshold between significant and nonsignificant correlations (p<0.05, 
n=32 for each time point). 
 
 
DISCUSSION 
Despite the very demanding constant posture conditions (64 hours in bed), our healthy study 
participants rated their subjective well-being in general as good and never attained low levels. 
As predicted, well-being was modulated by time of day (worse during the biological night 
than during the biological day) and by sleep pressure (worse during SD than NAP). This 
confirms an important role of the circadian and the sleep-wake homeostatic system on 
subjective well-being, modified by age and gender. In the following section we will discuss 
the impact of the different factors. 
 
Circadian modulation and sleep pressure 
The time of day modulation of subjective well-being was prominent in both protocols, 
indicating that circadian phase plays a pivotal role in well-being. This is in accordance with 
forced desynchrony data in which a significant circadian component of mood regulation could 
be educed (Boivin, Czeisler et al. 1997; Koorengevel, Beersma et al. 2003). Not clear is the 
role of wakefulness duration on mood, visible in our CR and in the short forced desynchrony 
protocol by Koorengevel et al., 2003 (Koorengevel, Beersma et al. 2003), but not in the 
classic study (Boivin, Czeisler et al. 1997). All our participants in the SD protocol showed 
deterioration of subjective well-being following 24 hours of wakefulness, declining about 4 
hours earlier in women than in men and improving again in young women already after 22 
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hours of prior wakefulness. Could women have had a higher motivation to overcome 
sleepiness? More plausible is the higher stress (see increased cortisol levels in the early 
evening, Figure 2.3) in our young female participants when they faced having to stay awake 
all night. The circadian component again was visible in the improved well-being that returned 
on day 2, despite very high sleepiness levels. 
Are women more vulnerable to circadian and sleep-homeostatic influences, or do they “sense” 
these changes better than men? Are men less “sensitive”, less attentive of their well-being, or 
are they more socially conditioned to not show negative emotions? Men had smaller circadian 
amplitude in well-being during high sleep pressure conditions, suggesting more stability. 
Indeed, well-being in men did not decline under high sleep pressure compared to low sleep 
pressure conditions, whereas it did in women. The near-linear pattern in young men was 
remarkable. Is this male insensitivity to circadian and sleep homeostatic alterations in well-
being and sleepiness related to higher risk-taking behaviours in young men, particularly when 
sleep deprived (e.g. their greater accident rate (Horne and Reyner 1995; Pack, Pack et al. 
1995)? Of course, there are major differences between real and simulated environments 
(Philip, Sagaspe et al. 2005), and cognitive performance is highly influenced by motivation 
(Hull, Wright et al. 2003). 
 
Age-effects 
Subjective well-being was significantly lower in our healthy older cohort than in the young, 
whether due to a decrease in subjective perception or diminishing physiological and/or 
psychological constitution. The demanding study protocol could have been experienced more 
negatively in the older group. Surprisingly, the older subjects did not show a reduced 
circadian modulation of well-being, as originally hypothesized, but a tendency to an even 
more prominent circadian rhythm in subjective well-being than young subjects.  
However, the older group responded to high sleep pressure with a significant greater 
deterioration in well-being than the young. This implies a greater vulnerability to changes in 
circadian phase and challenges of sleep pressure with age.  In contrast, other measures such as 
psychomotor vigilance performance appear less vulnerable to sleep debt in the older, not only 
in our study (Adam, Retey et al. 2006; Blatter, Graw et al. 2006). Even middle-aged subjects 
are less vulnerable than the young in this aspect of behaviour (Philip, Taillard et al. 2004; 
Bliese, Wesensten et al. 2006). Thus we could only partially confirm previous findings 
(Brendel, Reynolds et al. 1990) of greater mood and performance disturbances after sleep loss 
in older subjects.   
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Other circadian parameters 
It is interesting to compare subjective well-being with other circadian parameters, such as 
subjective sleepiness, melatonin [data already partially published (Cajochen, Knoblauch et al. 
2001; Knoblauch, Martens et al. 2003; Cajochen, Knoblauch et al. 2004; Knoblauch, Munch 
et al. 2005; Munch, Knoblauch et al. 2005; Cajochen, Munch et al. 2006)] and cortisol 
concentrations. Although our results indicate that subjective sleepiness and cortisol levels 
were significantly correlated with subjective well-being, these variables had dissimilar time 
courses under both protocols. Increasing sleepiness under high sleep pressure exhibited 
significant repercussions on subjective well-being in the early morning when increased 
homeostatic sleep load coincided with maximal circadian drive for sleep (corresponding time 
of day: 4 am, figure 2.4), but not when highest sleep pressure (38-40 hours) coincided with 
the maximal circadian drive for wakefulness in the evening (corresponding time of day: 10 
pm -midnight the second day of the protocol, figure 2.4). In contrast, sleepiness under low 
sleep pressure manifested a circadian rhythm similar to subjective well-being, but no 
significant correlation between these measures were observed at any given time point. Thus, 
the relationship between subjective sleepiness and well-being is not trivial but depends on a 
complex interaction between the circadian pacemaker and the sleep homeostat. 
The circadian melatonin and cortisol profiles followed the well-known temporal dynamics 
under CR conditions [reviewed in (Arendt 2006)]. The cortisol rhythm did not change with 
age, but nocturnal melatonin was significantly attenuated. We do not have any explanation for 
the lower nocturnal melatonin levels in young men – apart from possible chance differences 
in this particular group (there are much greater inter-individual differences in melatonin than 
there are differences between men and women (Arendt 2006)). The elevated cortisol levels 
around the evening nadir in young women may have reflected their more “stressful” reaction 
to the SD protocol, and this was correlated with well-being in a backward regression analysis. 
However, other studies have shown no or only minimal stimulation of cortisol secretion by 
sleep deprivation (Scheen, Byrne et al. 1996; Brun, Chamba et al. 1998). 
 
Limitations of the study 
Measuring behaviour under highly controlled laboratory conditions is important to assess 
contributions of circadian and homeostatic processes to a subjective variable such as well-
being. However, the results are not directly applicable to understanding squeal of a chronic 
sleep deficit caused by sleep problems or shift work in real life. Chronic partial sleep 
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restriction shows a different dynamic profile than acute total sleep deprivation (Banks and 
Dinges 2007), and a much smaller change in subjective ratings (Brunner, Dijk et al. 1993; 
Belenky, Wesensten et al. 2003).   
 
CONCLUSION 
Our results demonstrate clear age and gender-related modification of circadian and sleep-
wake-homoeostatic contributions to subjective well-being. In general, both older adults and 
women were more affected by sleep deprivation, showing a tendency to lower subjective 
well-being and a prominent circadian trough. Given that circadian and sleep homeostatic 
processes regulate mood in healthy subjects, it is not surprising that the circadian 
dysregulation and sleep disturbances associated with depression may have profound 
detrimental effects on mood in depressed patients, thus further perpetuating the disorder. 
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ABSTRACT 
Study Objectives: Major depressive disorder (MDD) is often associated with disturbances in 
circadian and/or sleep-wake dependent processes, which both regulate daytime energy and 
sleepiness levels. 
Design: Analysis of continuous electroencephalographic (EEG) recordings during 40 h of 
extended wakefulness under constant routine conditions. Artifact-free EEG samples derived 
from 12 locations were subjected to spectral analysis. Additionally, half-hourly ratings of 
subjective tension and sleepiness levels and salivary melatonin measurements were collected. 
Setting: Centre for Chronobiology, Psychiatric Hospitals of the University of Basel, 
Switzerland.  
Participants: Eight young healthy women and 8 young untreated women with MDD. 
Interventions: N/A. 
Measurements and Results: MDD women exhibited higher frontal low-frequency (FLA) 
EEG activity (0.5-5.0 Hz) during extended wakefulness than controls, particularly during the 
night. Enhanced FLA was paralleled by higher levels of subjective sleepiness and tension. In 
MDD women, overall FLA levels correlated positively with depression scores. The timing of 
melatonin onset did not significantly differ between the two groups, but the nocturnal 
secretion of salivary melatonin was significantly attenuated in MDD women. 
Conclusions: Our data imply that young women with MDD live on a higher homeostatic 
sleep pressure level, as indexed by enhanced FLA during wakefulness. Its positive correlation 
with depression scores indicates a possible functional relationship. High FLA could reflect a 
use-dependent phenomenon in depression (enhanced cognitive rumination or tension) and/or 
an attenuated circadian arousal signal. 
 
 
Keywords: Major depressive disorder, women, frontal low-frequency EEG activity, 
subjective sleepiness, extended wakefulness, circadian rhythms, sleep-wake homeostat 
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INTRODUCTION 
Major depressive disorder (MDD) is often associated with a dysregulation in circadian 
rhythmicity and/or sleep regulation. Abnormal circadian rhythms in many variables have been 
reported over the years, ranging from core body temperature, neurotransmitters and hormones 
to physiology of the sleep-wake cycle itself (Boivin 2000; Germain and Kupfer 2008). 
Characteristics of the circadian system (amplitude, phase and/or endogenous period) can be 
measured under very stringent laboratory conditions using markers such as core body 
temperature or melatonin. Although both delayed and advanced phase have been found in 
patients with MDD, several studies using highly controlled protocols such as the constant 
routine (Buysse, Monk et al. 1995; Wirz-Justice 1995) or forced desynchrony routines 
(Koorengevel, Beersma et al. 2002) (Koorengevel, Beersma et al. 2003) could not confirm 
circadian phase changes in MDD. However, reduced circadian amplitude seems to be more 
generally present (Souetre, Salvati et al. 1989; Wirz-Justice 1995; Armitage 2007; Germain 
and Kupfer 2008). 
The process S-deficiency hypothesis postulates a deficiency in the homeostatic build-up of 
sleep pressure during wakefulness in MDD, leading to a shallower dissipation rate of process 
S during sleep (Borbely and Wirz-Justice 1982; Kupfer, Ulrich et al. 1984; Wirz-Justice 1995; 
Armitage, Hoffmann et al. 2000; Wirz-Justice 2006). Changes in homeostatic sleep regulation 
can be quantified by spectral EEG correlates in the low frequency range (1-7 Hz) during sleep 
and wakefulness (Torsvall and Akerstedt 1987; Aeschbach, Matthews et al. 1997; Aeschbach, 
Matthews et al. 1999; Borbely and Achermann 1999; Finelli, Baumann et al. 2000; Makeig, 
Jung et al. 2000; Cajochen, Wyatt et al. 2002). The intensity of low-frequency EEG activity at 
the beginning of sleep is proportional to the duration of prior wakefulness, and is considered 
to reflect the homeostatic aspect of sleep regulation (Borbely 1982; Daan, Beersma et al. 
1984; Tobler and Borbely 1986). During sustained wakefulness, EEG activity in the 1-7 Hz 
range increases and can predict the subsequent homeostatic increase in slow-wave activity 
(SWA, EEG power density between 0.75-4.5 Hz) during sleep (Cajochen, Khalsa et al. 1999; 
Finelli, Baumann et al. 2000; Cajochen, Knoblauch et al. 2001), a phenomenon that is 
particularly pronounced in frontal brain regions (Cajochen, Khalsa et al. 1999; Cajochen, 
Knoblauch et al. 2001). This increased propensity in frontal low-frequency EEG activity 
(FLA) during sustained wakefulness suggests that frontal regions are more susceptible to 
sleep deprivation effects than other cortical regions (Horne 1993; Cajochen, Khalsa et al. 
1999).  
  44 
The process S deficiency hypothesis for MDD has rarely been tested in either sleep or waking 
EEG. An early study found lower delta waves during sleep in depressed patients (Kupfer, 
Ulrich et al. 1984), which was later documented only in males with MDD (Armitage, 
Hoffmann et al. 2000). In untreated middle-aged depressives, there was no difference from 
controls in SWA during sleep (Landolt and Gillin 2005).   
Similarly, EEG studies during wakefulness in depression are contradictory and inconclusive 
(Pollock and Schneider 1991). It is surprising that this has not received more attention, since 
waking EEG-derived indices are a desirable biological measure in psychiatric disorders, given 
its practicability, low budget, and possibility of a greater number of recording sites (Pollock 
and Schneider 1991).  
Thus, here was aimed at investigating sleep-homeostat and circadian-related differences in the 
EEG during extended wakefulness in MDD and healthy women under very stringently 
controlled laboratory conditions.  
Our main hypotheses were as follows: 
1. Women with MDD undergo a deregulation of sleep-wake homeostasis in comparison  
to healthy women, as indexed by an altered time course in EEG power density in the 
1-5 Hz range during 40 h of extended wakefulness, particularly in frontal derivations, 
which are more susceptible to the effects of prolonged wakefulness. 
2. Based on these alterations in sleep-wake homeostasis, which can affect subjective  
parameters, women with MDD experience higher subjective sleepiness and tension 
levels during 40 h of extended wakefulness.  
3. Women with MDD show attenuated amplitude and/or circadian phase advance or  
 delay in the rhythm of melatonin secretion. 
 
METHODS 
Study participants  
All study participants were recruited via advertisements at different Swiss universities and on 
online job advertisement pages for students. A total of 900 candidates were enrolled as 
potential participants, and all completed a general questionnaire on their health status, 
medication and shift work, as well as a Beck Depression Inventory (BDI), Pittsburgh Sleep 
Quality Index (PSQI), and a Chronotype questionnaires. Out of these candidates, 80 young 
women were interviewed (SCID-I), and 25 volunteers were selected for study participation. 
Of these 25, 16 young women (mean age 24±4.8y [SD]) participated in the study. Most of the 
potential participants were excluded since they had evening chronotype or high PSQI (>8). 
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All women were experiencing an episode of a MDD when undertaking the study protocol and 
fulfilled the diagnostic criteria of MDD according to the DSM-IV-TR. The main reason to 
include only women was based on the greater prevalence rate of MDD (without co-morbidity) 
in women then men.  
Since all of our depressed women were rather young, they did not have a long history of 
depression. The depressed participants experienced either the first or the second onset 
episode; none of them had been given psychiatric (including psychotropic drugs) treatment 
before the study. The episode duration was ≥ 2 weeks, according to DSM-IV-TR criteria 
(prior mean duration in month 11.18±7.6 months). They had no atypical symptoms, did not 
experience severe sleep problems, as measured by the Pittsburgh Sleep Quality Index (PSQI ≤ 
8; mean PSQI 6.5±1.6) (Buysse, Reynolds et al. 1989), and did not exhibit any comorbid 
psychiatric DSM-IV-TR-disorder. Each participant underwent a clinical interview, which was 
performed by the same clinical psychologist (ABP). This interview comprised the structured 
clinical interview for DSM-IV Axis I Diagnoses of existing symptoms (SCID-I; mean: 
5.15±0.37 SD) (Wittchen, Wunderlich et al. 1996), the Hamilton-17 scale, the structured 
interview guide for the Hamilton depression rating scale with atypical depression supplement 
(SIGH-ADS; mean for HAMD-17: 12.29±2.49 SD) (Ramos-Brieva and Cordero-Villafafila 
1988; Janet, Williams et al. 2003), the Montgomery-Åsberg Depression Scale (MADRS; 
mean: 16.71±2.13 SD) (Montgomery and Asberg 1979) and the Beck Depression Inventory 
(BDI; mean value 21.29±6.84 SD) (Beck, Ward et al. 1961). Half of the 16 MDD women 
were allocated to a high sleep pressure protocol (i.e. 40 h of extended wakefulness under 
constant routine conditions), while the other half participated in a low sleep pressure protocol 
(to be reported elsewhere). 
The control sample comprised 8 healthy young women (age range: 20-31 years; mean age 
25±3.3years, without any sleep problems [mean PSQI 2±1.63] (Knoblauch, Martens et al. 
2003; Birchler-Pedross, Schroder et al. 2009). All study volunteers underwent a physical 
examination as well as an interview about sleep quality, life habits and health state. They 
were free of any medication intake or treatment (except oral contraceptives) for ≥ 2 months; 
they had no neurological or sleep disorders. Sleep efficiency did not differ in the 2 groups 
(P=0.54) measured by wrist actigraphy (mean value for MDD 88.67±4.3 SD; for healthy 
92.41±4.0 SD). Volunteers were included only if their clinical sleep EEG scoring had no 
pathological findings (apnoea/hypopnoea-index [AHI] < 10/h; periodic leg movements [PLM] 
index <10/h). To exclude chronotype-specific differences in circadian phase preference we 
selected only moderate chronotypes (morning-evening-type [M/E] questionnaire rating 
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between 14 and 21 points) (Torsvall and Akerstedt 1980). Thus, chronotype was not 
significantly different between the 2 groups (controls 15.6±3.6 vs. depressive 16.1±1.3), nor 
was the body mass index (BMI, 21.2±2.5 for the depressive and 20.9±1.4 for the healthy 
volunteers). All participants were nonsmokers and without any drug abuse, as verified by 
urinary toxicological analysis sensitive for amphetamines, benzodiazepines, opiates and 
tetrahydrocannabinol (Drug-Screen Card Multi- 6®, von Minden GmbH, Moers, Germany). 
Participants were also required to abstain from excessive caffeine and alcohol consumption 
and heavy physical exercise. They indicated ≤ 3 cups of caffeinated beverages per day and  ≤ 
10 glasses of alcohol per week. Other exclusion criteria were: shift work within 3 months and 
transmeridian flights within 1 month prior to the study.  All women (from both depressed and 
healthy controls) started the study on days 1–5 after menses onset in order to complete the 
entire study block within the follicular phase. Three women with MDD and five control 
women used oral contraceptives. Thus, our study group included 8 young women with MDD 
and 8 healthy controls. While this sample seems rather low, the study was been carried out 
under very controlled laboratory condition of a constant routine (CR). In addition, prior to the 
study, participants were required to adhere to a regular sleep-wake cycle as verified by 
actimetry and sleep logs and all spent an adaption night in the laboratory. Thus, this procedure 
significantly reduced variability in the output measures. 
All procedures conformed to the Declaration of Helsinki. The local ethics committee 
approved the study protocol, screening questionnaires and consent form (Munch, Knoblauch 
et al. 2004; Munch, Knoblauch et al. 2007), and all study participants gave signed informed 
consent. 
 
Study design 
Each participant was instructed to maintain a regular sleep–wake cycle (bed- and wake-times 
within 30 min of self-selected target time), verified by wrist activity monitors (Cambridge 
Neurotechnology®, UK) and sleep logs for one week prior to the “in laboratory” part of the 
study. The entire study design entailed 2 protocols, one for high sleep pressure conditions and 
one for low sleep pressure conditions, with 8 controls and 8 depressive volunteers in each 
protocol. Participants were assigned randomly to either the low and high sleep pressure 
protocol. The treatment order (“sleep deprivation” vs. “nap protocol”) was counterbalanced in 
order to avoid possible order effects. Here, we focus only on the high sleep pressure protocol, 
which comprised an 8-h full polysomnography night in the laboratory, followed by 3.5 days 
consecutive days in the laboratory. During day 1, participants adjusted to the experimental 
  47 
dim light condition (<8 lux). After a second 8-h sleep episode, all volunteers participated in a 
40-h sleep deprivation protocol under controlled conditions (constant routine) (Cajochen, 
Khalsa et al. 1999; Cajochen, Knoblauch et al. 2001; Knoblauch, Munch et al. 2005) (Duffy 
and Dijk 2002), followed by a recovery night. The timing of the 8-h sleep episode was 
calculated with respect to the midpoint of each individual’s habitual sleep episode, as assessed 
by actigraphy and sleep logs during the baseline week. All wake episodes were spent under 
semi-recumbent constant routine conditions (<8 lux) during wakefulness, with a minor shift to 
supine posture during scheduled sleep episodes (0 lux) (Cajochen, Knoblauch et al. 2001).  
 
EEG Recording, Subjective Ratings, and Melatonin during Wakefulness 
The Karolinska Drowsiness Test (KDT) (Akerstedt and Gillberg 1990; Gillberg, Kecklund et 
al. 1994) was performed every hour during scheduled wakefulness, starting 1 hour after 
habitual wake time. During the KDT, volunteers were instructed to relax, to keep their eyes 
open, and to avoid movement for 3 min, during which they had to fixate on a 5-cm dot 
attached to the wall at 1.5 m distance. These instructions were intended to maximize signal 
quality. Waking EEG activity was recorded continuously during the 40 h of extended 
wakefulness, using the Vitaport Ambulatory system (Vitaport-3 digital recorder TEMEC 
Instruments BV, Kerkrade, the Netherlands). Twelve EEG derivations (F3, F4, Fz, C3, C4, 
Cz, P3, P4, Pz, O1, O2, Oz referenced against linked mastoids), 2 electrooculograms, one 
submental electromyogram, and one electrocardiogram were recorded. All EEG signals were 
filtered at 30 Hz (fourth-order Bessel-type antialiasing low-pass filter, total 24 dB/Oct), and a 
time constant of 1.0 second was used prior to online digitization (range 610 µV, 12 bit AD 
converter, 0.15 µV/bit; storage sampling rate at 128 Hz). The raw signals were stored online 
on a Flash RAM Card (Viking, Rancho Santa Margarita, CA, USA) and downloaded offline 
to a PC hard drive. EEGs were subjected to spectral analysis using a fast Fourier transform 
(10% cosine 2-second window), which resulted in a 0.5-Hz resolution. The 3-min EEGs 
during the KDT were manually and visually scored for artefacts (eye blinks, body 
movements, and slow eye movements) offline. Approximately 80% of the waking EEG data 
was used after rejecting for epochs with artefacts. The absolute EEG power densities were 
then calculated for artefact-free 2-s epochs in the frequency range of 0.5 to 20 Hz. For data 
reduction, artefact free 2-s epochs were averaged over 20-s epochs (Cajochen, Knoblauch et 
al. 2001).  
Subjective sleepiness was assessed every 30 min on the Karolinska Sleepiness Scale (KSS) 
(Gillberg, Kecklund et al. 1994). Subjective tension was assessed by a 100-mm bipolar VAS 
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at 30-min intervals. The participants were asked to indicate how they felt “at the moment” by 
placing a vertical mark on the VAS ranging from 0 (“worst ever”) to 100 mm (“best ever”). A 
similar VAS rating for mood was also made (Birchler-Pedross, Frey et al. 2010). 
Salivary collections for hormonal assays were scheduled during wakefulness at the same 30-
min intervals as for the subjective ratings. A direct double-antibody radioimmunoassay was 
used for the melatonin assay (validated by gas chromatography–mass spectroscopy with an 
analytical least detectable dose of 0.65 pm/ml; Bühlmann Laboratories, Schönenbuch, 
Switzerland (Weber, Schwander et al. 1997)). The functional least-detectable dose using the 
less than 20% coefficient of interassay variation criterion was < 0.65 pg/mL, and individual 
serum and saliva melatonin profiles showed excellent parallelism (r=0.977– 0.999; slopes 
=0.21– 0.63) (Weber, Schwander et al. 1997).   
 
Statistics  
For all analyses, the statistical packages SAS® (SAS Institute Inc., Cary, NC, USA; Version 
6.12) and Statistica® (Stat-Soft Inc., 2000–2004, Statistica for Windows, Tulsa, OK, USA) 
were used. Repeated measure analyses of variance (rANOVAs) with the between factor 
“group” (depressive vs. control). We also considered the within factor “derivation” (EEG-
channels: F3, Fz, F4, C3, Cz, C4, P3, Pz, P4, O1, Oz, O2) and the within factor “time-of-day” 
(11 time points; The 3.75-h interval came about 150 min of wakefulness followed by 75 min 
of the corresponding scheduled sleep (nap). This duration allows starting the recovery night at 
the same clock time [circadian phase] as the baseline night, since it replaced the last 
scheduled nap). These 3 factors (“group”, “derivation”, and “time-of-day”) were performed 
for each 0.5-Hz frequency bin separately in the range of 1-20 Hz. Since we did not observe 
consistent left-right changes in MDD women vs. control women, frontal (F3, Fz, F4), central 
(C3, Cz, C4), parietal (P3, Pz, P4) and occipital derivations (O1, Oz, O2) were collapsed per 
subject into a single frontal derivation (average [F3, Fz, F4]),  a single central (average [C3, 
Cz, C4]), a single parietal (average [P3, Pz, P4]) and a single occipital derivation (average 
[O1, Oz, O2]). Frequency bins yielding significance for the interaction “group x derivation” 
were collapsed into frequency bands, averaged per 3.75-h bin per study volunteer, and 
subjected to a rANOVA with the factors “group”, “derivation” and “time-of-day”. Similarly, 
the 30 min subjective ratings and melatonin values were collapsed into 3.75-h time bins 
resulting in 11 time points and subjected to rANOVAs with the factors mentioned above. All 
P-values derived from rANOVAs were based on Huynh-Feldt’s (H-F) corrected degrees of 
freedom (significance level: P < 0.05). Alpha adjustment for multiple comparisons was 
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applied according to Curran-Everett (Curran-Everett 2000). Pearson’s correlation coefficients 
were computed to compare individual FLA levels with depressions scores derived from the 
MADRS and Hamilton-7-Item scale in MDD women.  
 
RESULTS  
EEG during Wakefulness 
Absolute spectral EEG power density for each frequency bin, for each derivation and for each 
derivation averaged over eleven 3.75-h time intervals yielded a significant “group” effect for 
the frequency bins between 1 and 2.5 Hz, a significant “derivation” effect for a broader 
frequency range 1-13Hz, (F3,42 ≥ 3.3) and 14.2-20 Hz (F3,42 ≥ 4.7), and a significant 
interaction “group” x “derivation” effect between 0.5 and 4 Hz (F3,42 ≥ 2.9) P < 0.05; Figure 
1). Similarly, when considering averaged derivations (frontal, central, parietal, occipital), a 
significant “group” effect was elicited between 0.5 and 2 Hz (F1,14 ≥ 4.6), and a significant 
(i.e. P < 0.05) “derivation” effect was elicited between 1-8 Hz (F3,42 ≥ 5.8), 9.5-12 Hz (F3,42 ≥ 
6.4) and 16.5-20 Hz (F3,42 ≥ 4.0). Furthermore, the interaction term “group” x “derivation” 
yielded significant differences between 0.5 and 5 Hz (F1, 3 ≥ 1.0). Thus, EEG power density in 
the 0.5- 5 Hz range was collapsed per subject in order to investigate the time course of low-
frequency EEG activity in the course of the 40-h episode of extended wakefulness.  
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Figure 3.1: Absolute EEG power spectra during extended wakefulness along the anterior-posterior axis (frontal, 
central, parietal, occipital). Women with MDD are indicated by closes dots and the control group by open 
symbols. Mean values are shown for each 0.5-Hz frequency bin in the range from 0.5 to 20 Hz. A significant 
“group x derivation” effect was observed between 0.5 and 5 Hz, and a significant group effect in the range of 
0.5-2 Hz. 
 
Overall, low-frequency EEG activity (0.5- 5 Hz) showed a similar time course in both women 
with MDD and control women (Figure 2), with no significant differences in the interaction 
terms “group” x “time” and “group” x “time” x “derivation”, although the interaction “group” 
x “derivation” yielded significant differences (F3,42= 2.9; P < 0.05), indicating a frontal 
predominance of the increase in low-frequency EEG activity in MDD women compared to 
the control women (Figure 2). 
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Figure 3.2: Dynamics of low-frequency EEG activity (EEG power density in the 0.5-5 Hz band) during 40 h of 
etended wakefulness. Data were binned into 3.75-h time intervals (mean values ±SEM, n=8) and plotted against 
relative time of day (h). Relative clock time represents the average clock time at which the time inetervals 
occurred. For statistics see text. Local derivations on waking-EEG are summarized as frontal derivation (mean 
of F3, F4, Fz) central derivation (mean of C3, C4, Cz), parietal derivation (mean of P3, P4, Pz), and occipital 
derivation (mean of O1, O2, Oz). 
 
For enhanced visual illustration, a global cortical contour plot with the entire topography is 
provided in Figure 3 for EEG power density in the 0.5-5 Hz range. Average low-frequency 
EEG activity indicated higher values in frontal and central derivations in the MDD than 
control women.  
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Figure 3.3: Colour-coded scalp topography of low-frequency EEG power density in the 0.5-5 Hz range 
averaged over 40 h of extended wakefulness in women with MDD (left head, n = 8) and control women (right 
head, n = 8). High temperature (yellow) represents high low-frequency EEG power density values, while low 
temperature (red) represents low values. Note: higher low-frequency EEG activity in MDD than control women, 
particularly in frontal and central brain regions. 
 
Visual inspection of the contour plot over time (Figure 4) showed that MDD women had 
particularly high low-frequency EEG activity during the subjective night and early morning, 
as well as at 15:00h on the second day of extended wakefulness. 
 
 
Figure 3.4: Time course of low-frequency EEG activity (in the range of 0.5-5 Hz) during 40 h of extended 
wakefulness. These contour plots (i.e. haeds ) describe the difference between low-frequency EEG activity in the 
MDD and control women across 11 time points in the high sleep pressure protocol. MDD women showed higher 
low-frequency EEG activity, particularly during the subjective niaght and early morning, as well as at 15:00 
during the second day. Maximum difference between MDD women and controls shown in yellow (max: MDD 
women > controls) and the minimum difference between the 2 groups is shown in light blue (max: controls > 
MDD women). 
 
Subjective Sleepiness  
The time course of subjective sleepiness ratings for MDD and control women during the 40-h 
of extended wakefulness are illustrated in Figure 5 (upper panel). The factor “group” yielded 
a tendency for higher sleepiness levels in MDD women (F1,15= 3.6; P = 0.07), and 
significance for the factor “time-of-day” (F10,150=17.1; P<0.001), the latter showing the 
expected circadian and wake-dependent modulation of sleepiness in both groups. Certain time 
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points (from 17 h, 21 h and 24 h elapsed time into protocol) during the biological night 
yielded significant higher sleepiness levels in the MDD than in the control women (F1,15= 6.8; 
P < 0.02). 
 
 
Figure 3.5: Time course of subjective sleepiness (Karolinska Sleepiness Scale, first panel), subjective tension 
(VAS, second panel), and salivary melatonin levels (third panel) across the 40 h of extended wakefulness. 
Women with MDD are plotted in closed dots, the healthy controls with open symbols (mean values ± SEM, n = 
8). 
 
Subjective Tension  
MDD women indicated significantly higher levels of subjective tension only after 20 h to 40 h 
of wakefulness compared to the control women (Figure 5, middle panel). Thus, the factor 
“group” yielded significance (F1,15= 12.9; P < 0.03), although no differences were observed 
for the factor “time-of-day” (F10,150= 0.81; n.s.) and the interaction ”group” x “time-of-day”. 
However, certain time points from 17 h, 21 h, 24 h, and 28 h elapsed time into protocol) 
during the biological night and next morning were significantly higher in the MDD women 
than in the control women (F1,15= 18.75; P = 0.0005). 
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Melatonin 
The time course of salivary melatonin levels is illustrated in Figure 5 (lower panel). The 
factor “group” yielded a tendency for lower melatonin levels in MDD than control women 
(F1,15= 3.7; P = 0.06).  The factor “time-of-day” yielded significance (F10,150= 16.2; P < 
0.001), and the interaction term “group” x “time-of-day” almost reached significance (F10,150= 
1.9; P = 0.05), indicating an attenuation of nocturnal salivary melatonin secretion in the MDD 
women. 
 
FLA and depression scores 
Pearson correlations revealed positive and significant correlations between FLA levels during 
extended wakefulness and depression baseline severity, derived from both the Hamilton-7 
Items (r = 0.75; P < 0.04) and MADRS (Figure 6; r = 0.8; P  < 0.02). 
 
Figure 3.6: Linear regression between the values of the depression score (MADRS; 8-20) on the x-axis and the 
value of FLA (y-axis) across 40 h of extended wakefulness (r = 0.8; P < 0.02). 
 
 
DISCUSSION 
Overall FLA during extended wakefulness was higher in MDD than in healthy control women 
and correlated positively and significantly with depression severity. The time course of 
enhanced FLA was paralleled by higher subjective sleepiness and tension levels in MDD than 
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in healthy control women. MDD women did not differ from controls in circadian melatonin 
phase, but showed a significant attenuation of melatonin secretion during the biological night. 
These are the first data in MDD addressing the waking aspect of the S deficiency hypothesis 
postulated by Borbély and Wirz-Justice (1982) (Borbely and Wirz-Justice 1982). 
Surprisingly, unmedicated, young women with MDD, a middle chronotype and almost no 
sleep disturbances seem to live on a higher - not the hypothesized lower - homeostatic sleep 
pressure, but with similar build-up rates during extended wakefulness as found for healthy 
controls. The sleep aspect of the S-deficiency hypothesis was also studied in this same cohort 
(to be reported elsewhere (Frey, Birchler-Pedross et al. 2010)), and they indeed showed 
elevated – not diminished - SWA levels during sleep. To our knowledge, there is only one 
early study that reported elevated SWA during wakefulness in right frontal brain regions in a 
mixed-gender group of MDD patients with a comparatively brief medication washout period 
(Knott and Lapierre 1987). Together with the significant correlation with the MADRS and 
Hamilton depression scores, elevated FLA levels in our MDD group women most likely 
reflect certain aspects of the disorder per se, and do not seem to be primarily caused by a 
sleep disorder or a major circadian misalignment. Thus, we speculate that the elevated FLA 
levels during wakefulness in an episode of major depression were a state rather than a trait 
marker in our MDD cohort. Support for this assumption also comes from elevated SWA 
levels during sleep in the same MDD women (Frey, Birchler-Pedross et al. 2010).  Our study 
sample comprised women with MDD who are unmedicated and without sleep disturbances. 
While this may not be a representative sample of patients with major depression, it should be 
emphasized that MDD itself is a heterogeneous group with symptoms that crucially depend 
on numerous aspects, such as duration of disorder. Most importantly, we could show that 
even in patients with MDD without medication and sleep disorders the homeostatic sleep 
regulation is significantly changed. In this context, one may speculate that changes in sleep 
homeostasis may anticipate and/or trigger a severe MDD episode, especially when 
considering that our sample included women with a mild episode of MDD. Similarly, FLA 
could also be seen as a compensatory mechanism and/or reaction to increased depressive 
levels, as indexed by an “over response” of the homeostatic sleep process when challenged by 
40 h of sleep deprivation.  
Interestingly, there is more recent works, running in a similar direction, showing that 
suppressing low-frequency activity in the EEG during sleep in MDD patients leads to mood 
improvements in those patients (Landsness, Goldstein et al. 2010). On the other hand, 
enhancing low-frequency activity during sleep marginally decreased positive mood in patients 
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with MDD (Cheng, Goldschmied et al. 2010). These two studies lend support to our finding 
that the amount of FLA is significantly related to depression severity.   
The topographic specificity of the increase in low-frequency activity – mainly frontal 
derivations – is an indication that women with MDD may be more susceptible to homeostatic 
sleep pressure, in particular the effects of prolonged wakefulness, possibly due to a high 
“recovery need” of frontal heteromodal association areas of the cortex, which are strongly 
affected by elevated sleep pressure as shown in PET studies (Thomas, Sing et al. 2000). 
Alternatively, our results of higher FLA could represent a biological correlate of higher 
cognitive rumination in MDD patients, known as “brooding”, which is a core process in the 
onset and maintenance of depression (Nolen-Hoeksema 1991; Nolen-Hoeksema 2000) 
Depressive rumination could be seen as a state of higher arousal during wakefulness, which 
could have resulted in elevated subjective tension. If slow wave homeostasis is associated 
with net synaptic strength, postulated by Tononi et al. to increase during wakefulness and 
decrease during sleep (Tononi 2009), then higher cognitive rumination should lead to higher 
FLA during wakefulness, and FLA could be a proxy of more intense upscaling of synaptic 
strength in MDD. Thus, one could speculate that our women with MDD had an altered 
regulation of synaptic plasticity.  Results from a recent study indeed support the hypothesis of 
a decreased synaptic plasticity in patients with MDD (Nissen, Holz et al. 2010). 
Enhanced FLA levels impact on the circadian timing system. There is recent evidence for a 
crosstalk between systems regulating sleep-wake homeostasis and endogenous circadian 
rhythmicity in the hypothalamus (Schmidt, Collette et al. 2009). High sleep pressure levels 
considerably suppressed activity in the anterior hypothalamus, including the suprachiasmatic 
area, the brain site of the central circadian pacemaker (Schmidt, Collette et al. 2009). Thus, 
the observed decrease of circadian melatonin secretion in our MDD cohort could reflect an 
attenuation of the circadian wake-promoting signal by increased homeostatic sleep pressure. 
This finding is consistent with previous forced desynchrony studies in seasonal affective 
disorder (SAD) patients (Koorengevel, Beersma et al. 2002; Koorengevel, Beersma et al. 
2003) and non-circadian protocols with depressed patients (Tononi 2009; Cheng, 
Goldschmied et al. 2010; Landsness, Goldstein et al. 2010).  
It may be that low nocturnal melatonin levels and indeed low amplitude in many other 
variables (Wehr and Wirz-Justice 1982; Knott and Lapierre 1987; Strogatz, Kronauer et al. 
1987; Dijk and Czeisler 1995; Lavie 2001; Koorengevel, Beersma et al. 2002; Koorengevel, 
Beersma et al. 2003) are a reflection of diminished circadian signal in MDD. Lack of an 
adequate wakefulness signal may permit the expression of increased FLA and sleepiness in 
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these patients. On the other hand, one could also argue that, since our results on the circadian 
system focus only on melatonin as a circadian marker that the attenuated profile of melatonin 
in MDD could also reflect impaired nocturnal melatonin secretion. Taken together, these 
findings provide a possible explanation as to why bright light exposure, which increases the 
amplitude of the circadian system, may improve depressive symptoms in MDD (Shirani and 
St Louis 2009).  
 
Limitations 
Measuring behaviour under highly controlled laboratory conditions is pivotal to assess the 
contributions of circadian and homeostatic processes to the EEG during wakefulness. Our 
sample comprised young, unmedicated, depressed women, and excluded those with sleep 
disturbances; thus, our findings are not representative for all patients suffering MDD. 
Likewise, the directionality of the results (MDD prior to changes in sleep homeostasis and 
vice-versa) cannot be predicted by this study design, since a cross-sectional design and a 
constant routine protocol cannot provide a causal effect for these results. However, since the 
only difference between the depressive and control women was the depression per se, we 
could ideally test whether the observed changes are related to circadian and/or sleep 
homeostatic alterations.  
 
CONCLUSION 
The concomitant findings of higher FLA, subjective sleepiness, tension, and attenuated 
melatonin levels in untreated young women with MDD under stringent laboratory conditions 
indicate that major depression per se is associated with impaired nighttime melatonin 
secretion and altered sleep-wake-homoeostatic processes.   
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ABSTRACT 
Diurnal mood variations are a key symptom in depression and also occur in healthy subjects. 
Total sleep deprivation (SD) in depressed patients can induce a rapid, but usually short-lasting 
clinical improvement. Here we investigated repercussions of differential sleep pressure levels 
(high vs. low) on diurnal mood levels in young women diagnosed with major depressive 
disorder (MDD) and healthy controls. Eight healthy women (mean age 25±3.3y) and eight 
women (mean age 14±4.8y) with MDD underwent a 40-h SD (high sleep pressure) and a 40-h 
nap (low sleep pressure attained with multiple naps) protocol under constant routine 
conditions. The volunteers rated their subjective mood every 30 minutes during scheduled 
wakefulness using a 100mm bipolar visual analogue scale. MDD women suffered from 
symptoms of “sadness”, “loss of interest”, “loss of energy”, “reduced feeling of self-worth”, 
“diminished concentration” and “social withdrawal” but not from insomnia as diagnosed by 
the Pittsburgh Sleep Quality Index and a full night sleep polysomnography.  
Under high sleep pressure conditions, diurnal mood variations were significantly modulated 
by the factors “group” (depressives vs. healthy), “time of day” (11 time points) and their 
interaction. Under low sleep pressure only a significant group effect was found. Overall, in 
both protocols, mood ratings were considerably lower in depressive women than in the 
control group. However, under SD women with MDD exhibited a more distinct circadian 
modulation of lower mood than controls. Despite this higher circadian variation of mood 
fluctuation, they did not profit from a significant and clinically relevant antidepressant effect. 
Our data imply that depressive women without sleep disturbances show a significantly 
different time course of mood during elevated sleep pressure (i.e. 40-h SD) than controls but 
not during low sleep pressure conditions (i.e. 40-h nap condition). The lack of a clear 
antidepressant effect suggests that the SD response could depend on the magnitude of 
insomnia, which is a frequent co-morbidity in depression.  
 
Key words: depression, sleep deprivation, constant routine, nap 
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INTRODUCTION 
Sleep deprivation (“wake therapy”), usually consisting of total sleep deprivation for one night 
or for the second half of a night, has been described as the most rapid antidepressant known, 
producing marked improvement within hours in approximately 60% of patients (reviewed in 
(Wirz-Justice, Benedetti et al. 2005). Total sleep deprivation (SD) in depressed patients with 
severe insomnia revealed unexpected and paradoxical antidepressant effects (Reinink, 
Bouhuys et al. 1990). Cross-sectional studies showed that diurnal variation of mood (DV), a 
key symptom of depression, appears to be a predictive patient characteristic such that patients 
with marked positive DV (better in the evening) tend to respond more favourably to SD than 
those with negative DV (worse in the evening) (Haug 1992; Haug and Wirz-Justice 1993). 
Even though the improvement following total SD is rapid, there is also a rapid return of 
depressive symptoms after subsequent sleep recovery. The rapid, usually short-lasting 
improvement following total SD and the rapid return of depressive symptoms after 
subsequent sleep recovery indicates that the depression may be linked to sleep-wake 
regulating processes (Wirz-Justice and Van den Hoofdakker 1999). This suggests a close link 
between depression and sleep-wake regulatory processes. Additionally, SD needs to coincide 
with an early morning circadian phase for an optimal antidepressant response (Wirz-Justice 
1998). A chronobiological model was proposed to explain sleep-wake cycle disturbances in 
major depression on the basis of the two-process model of sleep-wake regulation (Borbely 
and Wirz-Justice 1982). This model attempts to explain the effects of SD, REM-sleep 
disinhibition and reduction of slow wave sleep (SWS) often seen in depressed patients as the 
result of a deficient sleep homeostatic process (Borbely and Wirz-Justice 1982). 
Sleep disturbance is one of the predominant symptoms associated with depression. 
Approximately 50-90% of depressed patients complain of difficulty falling asleep, staying 
asleep or experiencing early morning awakening or impairment of sleep quality (Casper, 
Redmond et al. 1985; Riemann, Berger et al. 2001). To our knowledge, there are no studies 
that describe SD as an antidepressant in depressive patients without sleep disturbances. Here 
we investigated whether differential sleep pressure levels (high vs. low), as a marker of the 
sleep homeostatic process, have significant repercussions on self-rated mood levels in young 
women diagnosed with major depressive disorder (MDD) without sleep disturbances 
compared to age-matched healthy controls. 
Our main hypotheses were as follows: 
1. Depressive women exhibit an improvement in subjective mood during the course of a 
40h   SD (high sleep pressure conditions) compared to controls. 
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2. Under low sleep pressure conditions (40h nap protocol), subjective mood of 
depressive women undergoes a more pronounced circadian modulation than under 
high sleep pressure, but does not show improvement compared to controls. 
 
METHODS 
Study participants  
All study participants were recruited via advertisement at different Swiss universities and on 
online job advertisement pages for students (for details see (Birchler-Pedross, Frey et al. 
2011). Sixteen young women (mean age 24±4.8y) participated in the study. All women 
fulfilled the complete diagnostic criteria of DSM-IV for MDD at the time of undertaking the 
study protocol. They had no atypical symptoms or other co-morbid psychiatric DSM-IV-
disorder, and were without severe sleep problems as measured by the Pittsburgh Sleep Quality 
Index (PSQI≤8) (Buysse, Reynolds et al. 1989); mean PSQI 5.5±1.6SD. Each participant 
underwent a clinical interview with the same clinical psychologist (ABP). This interview 
comprised the structured clinical interview for DSM-IV Axis I Diagnoses of existing 
symptoms (SCID-I; mean: 5.15±0.37 SD) (Wittchen, Wunderlich et al. 1996). The study 
subjects had all of the following symptoms at the time of the SKID Interview; “sadness”, 
“diminished interest or pleasure”, “energy loss”, “reduced feeling of self-worth”, “diminished 
concentration”, and “social withdrawal”; six women described very moderate symptoms of 
“sleep disturbances”. Clinical status was further estimated by the Structured Interview Guide 
for the Hamilton Depression Rating Scale with Atypical Depression Supplement (SIGH-
ADS) (Janet, Williams et al. 2003), which consists only of the Hamilton-17 item scale (mean: 
12.29±2.49 SD) plus atypical items (Standard Value for HAMD-17 ≥8), the Montgomery-
Åsberg Depression Scale (Montgomery and Asberg 1979) (MADRS: mean 16.71±2.13) 
(Standard Value for MADRS ≥ 13), the Beck Depression Inventory (Beck, Ward et al. 1961) 
(BDI: mean 21.29±6.84) (Standard Value for BDI ≥12). The “Mehrfachwahl-Wortschatz-
Intelligenz-Test” (MWT-B: mean 30.37±2.5) was used for assessing intellectual ability. Two 
weeks after running the study there was a BDI (mean 22.5±11) follow up. 
 
The age-matched control subjects were eight healthy young women (age range 20-31y; mean 
25±3.3y) who were medically screened and had no prior psychiatric illness (for further 
detailed information on the recruitment of the control subjects see (Knoblauch, Martens et al. 
2003; Birchler-Pedross, Schroder et al. 2009)). None of the study volunteers were taking any 
medication, nor were they undergoing any kind of treatment. All study volunteers were free of 
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neurological and other sleep disorders, as assessed by a full night polysomnographic 
screening (PSG). To exclude chronotype-specific differences in circadian phase preference, 
only moderate chronotypes (morning-evening-type questionnaire rating between 14 and 21 
points (Torsvall and Akerstedt 1980)) were selected. However, depressive study volunteers 
tended to be more evening types (16.1±1.3) than controls (15.6±3.7; p=0.066, t-test), although 
this difference was rather small. Body mass index (BMI) did not significantly differ between 
the groups (21.2±2.5 for depressive study volunteers and 20.9±1.4 for the healthy volunteers). 
All participants were non-smokers without any drug abuse, and were also required to abstain 
from heavy physical exercise, shift work and transmeridian flights before the study. All 
women started the study on days 1–5 after menses onset in order to complete the entire study 
block within the follicular phase, with the exception of three depressive and five control 
women taking oral contraceptives. All procedures conformed to the Declaration of Helsinki 
and the local Ethical Committee [for details see (Munch, Knoblauch et al. 2004; Munch, 
Knoblauch et al. 2007)]. 
 
Protocol and study design 
Each participant was instructed to maintain a regular sleep–wake cycle (bed- and wake-times 
within ±30 min of self-selected target time), which was verified by wrist activity monitors 
(Cambridge Neurotechnology®, UK) and sleep logs during one week prior to the study. The 
entire study design entailed two protocols; one for high and one for low sleep pressure 
conditions. In each protocol we included eight control and eight depressive volunteers. The 
eight healthy control subjects carried out a crossover design participating in both protocols. In 
the depressive cohort, we recruited 16 study volunteers and distributed them randomly to 
either the high or low sleep pressure protocol. Each protocol comprised 3.5 days and started 
with an 8h PSG night in the laboratory. During day 1, the study volunteers adjusted to the 
experimental dim light condition (<8 lux). After a second 8h sleep episode, the volunteers 
participated in either a high sleep pressure condition (40h SD) or in a low sleep pressure 
condition (multiple nap protocol) under strictly controlled constant routine (CR) conditions 
(Cajochen, Khalsa et al. 1999; Cajochen, Knoblauch et al. 2001), which was followed by a 
recovery night sleep. The timing of the 8h sleep episode was calculated with respect to the 
midpoint of each individual’s habitual sleep episode as assessed by actigraphy and sleep logs 
during the baseline week. All wake episodes were spent under semi-recumbent CR conditions 
(<8 lux) during wakefulness with a minor shift to supine posture during scheduled sleep 
episodes (0 lux).  
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Mood ratings 
During the protocol, mood was assessed among the MDD women’s means of different mood 
self- and foreign rating scales to different time points such as the Adjective Mood Scale 
(AMS, in its German version “Befindlichkeitsskala”) (Von Zerssen and Koeller 1976), 
Montgomery Åsberg Scale (Montgomery and Asberg 1979), Hamilton-Depression Scale 7-
Items German version analogous to  (McIntyre, Konarski et al. 2005) and Visual Analogue 
Scale (VAS) for subjective mood.  
In this paper, the subjective mood (VAS) and the Hamilton-Depression scale 7 items 
(HAMD-7) are presented: 
Subjective mood was assessed by a 100mm bipolar visual analogue scale (VAS) at 30-min-
intervals in both groups. The participants were asked to indicate how they felt “at the 
moment” by placing a vertical mark on the VAS ranging from 0 (“worst ever”) to 100mm 
(“best ever”).  
The following rating was only assessed in the depressive group, which allows comparisons 
only between the two different protocols in the same group. The foreign rating scale, namely 
the Hamilton-Depression scale 7 items (HAMD-7), the abbreviated HAMD-7 depression 
scale, which was essential because of its short duration in the elaborate Constant Routine 
Protocol. This rating-scale is a short version of the Hamilton 17 (McIntyre, Konarski et al. 
2005) with the items “depression mood”, “feeling of guilt”, “interest, pleasure, level of 
activity”, “tension and nervousness”, “physical symptoms of anxiety”, “energy level”, and 
“suicide”. Important to notice is that this rating has no sleep item (score 4 ≥ indicates 
non/partial Remission; score 3≤ indicates full remission). This rating was carried out during 
the baseline before the protocol (morning), and at 4 time points at about 2h (morning), 14h 
(evening), 26h (morning) and 36h (evening) into the high or low sleep pressure protocol. 
 
Data analyses and statistics 
For data reduction, all values of subjective mood were collapsed into 3.75h bins per subject 
before averaging over subjects. For all analyses, the statistical packages SAS® (Version 6.12; 
SAS Institute Inc., Cary, NC) and Statistica® (Stat-Soft Inc., 2000-2004, STATISTICA for 
Windows, Tulsa, OK) were used. For the observer and self-ratings, the SPSS® (SPSS Inc, 
SPSS for Windows, Chicago, IL, USA, and Version 17) was used. Two-way measures 
ANOVA and the Procedure mixed with the factors “group” (depressive vs. control) and “time 
of day” (11 time points) were applied for each protocol (SD and NAP) separately. All p 
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values were based on Huynh-Feldt’s (H-F) corrected degrees of freedom (significance level 
p<0.05). At some time points data were not normally distributed, and thus a nonparametric 
test was used for post hoc comparisons (Mann-Whitney U test). The self- and observer ratings 
were analysed using a global mean for each protocol and then t-tests for independent samples 
at Levene’s Test for Equality of Variance.  
 
RESULTS 
Subjective Mood: The MDD women in the high sleep pressure protocol (40h SD) rated 
marginally, but not significantly, better than those who were assigned to the low sleep 
pressure protocol (40h Nap). However, both the MDD women in the low and high sleep 
pressure protocol were significantly worse than the controls.   
The time courses of mood ratings for MDD and control women are illustrated in Figure 1.   
 
Figure 4.1: Time course of subjective mood (100mm visual analogue scale) during the 40h high sleep pressure 
protocol (upper panel) and during the 40h low sleep pressure protocol (lower panel). Mean values ± SEM (N=8 
for controls and N=16 for depressed). Depressed women are plotted in filled black symbols, the healthy controls 
with open symbols. 
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Under high sleep pressure conditions, variations in the time course of subjective mood was 
significantly determined by the main factors “group” (depressed vs. healthy women; 
p=0.0003), “time elapsed” (11 time points, p=0.0005) and the interaction of the two factors 
(p=0.04). A post-hoc comparison yielded significantly worse mood in the MDD women at the 
time points 9h and 13h, as well as from time point 24h to 22h the next day. Under low sleep 
pressure conditions, subjective mood yielded a significant group effect (p=0.005), but neither 
a significant time effect nor a significant interaction effect. 
 
Figure 4.2: Estimation of depression levels by observer ratings using the Hamilton-7 Item short depression scale 
during a baseline (the night before the protocol start) and 4 time points during the high (black bar) and low 
(grey bar) sleep pressure protocol. Mean values + SEM.   
 
The Hamilton-7 Items observer rating (Figure 2) yielded significance for the global mean 
between the high and low sleep pressure protocol (p=0.04, t-test). Comparison of each of the 
5 time points between the two protocols revealed only one significant value at 22h; after 14 
hours into the protocol (p=0.0315). No significant effect was found at >20 hours of sustained 
wakefulness compared with baseline. Calculation with non-parametric methods yielded the 
same results.  
 
A linear regression between the PSQI-values and subjective mood using the visual analogue 
scale (VAS) during high sleep pressure protocol at the time points “differences of point 6 and 
8”, i.e. after 21h minus 28h yielded a regression of r=0.75 (Figure 3). 
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Figure 4.3: Linear Regression between the values of PSQI and the values of mood from the visual analogue 
scale (1 to 100) in the high sleep pressure protocol. This figure shows the difference between point 6 and 8, i.e. 
after 21h minus 28h during the 40h of wakefulness (see Figure 1 high sleep pressure protocol).  On the x-axis 
PSQI values from 4 (the lowest value given) to 8 (the highest value given) are shown. On the y-axis, the 
difference between point 6 minus 8 of the mean values of the VAS of subjective mood are shown. Regression: 
r²=0.57. The black dots are the individual PSQI minus mood point. 
 
 
DISCUSSION 
In this small group of untreated young MDD women with a mild depressive episode, a middle 
chronotype and almost no sleep disturbances, total SD did not lead to an antidepressant effect 
when comparing subjective mood ratings of MDD (VAS) women after >20 hours of sustained 
wakefulness with controls. This is the subjective mood rating of MDD women under high 
sleep pressure conditions compared to controls. Although there seems to be a very short-term 
improvement in mood observed at around 24h of elapsed time awake in the high sleep 
pressure protocol of subjective mood ratings when compared to time points in close vicinity. 
In the HAMD-7 Items rating, the time point after 14h of wakefulness was significantly better 
after SD when compared with sleep satiation. These discrete observable mood-elevating 
effects indicate that modulating sleep can have effects, albeit short, in depressed patients. 
However, the mood levels in the MDD women never attained the levels of the healthy control 
women. Likewise, the mood-elevating effects occurred only after 20 hours of wakefulness 
had elapsed, rather than continuously, as we would expect for a full SD effect. 
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These findings suggest that SD yields no antidepressant effect in young depressive women 
with major depression without insomnia. For this analysis we used two different kinds of 
measurement; a subjective visual analogue scale every half hour and one foreign rating every 
12 hours. All measurements yielded a consistent result. The therapeutic effect of SD has often 
been described in terms of chronobiological models (Wirz-Justice, Tobler et al. 1981; Van 
den Hoofdakker, Beersma et al. 1986) and seems to not fit with our depressive cohort. 
According to different hypotheses of phase angle or circadian shift in non-seasonal depression 
and the reported results of SAD patients (Graw, Haug et al. 1998; Koorengevel, Beersma et 
al. 2003) in our cohort we did not observe a significant difference between the MDD women 
and control volunteers (Frey unpublished data). Our data questions the causes behind this 
non-significant antidepressive SD effect.     
The fast but short-lasting improvement of depressive symptoms by SD in about 60% of 
patients with a major depressive disorder is well established, but the mechanisms of this are 
still not clear. A high delta sleep ratio is a positive predictor for SD response (Nissen, Feige et 
al. 2001), which could not be confirmed in our MDD women. Certainly, we found that the 
MDD women may live on a higher level of homeostatic sleep pressure manifested by EEG 
slow-wave activity (SWA 0.75-4.5 Hz) during baseline sleep, and recovery sleep from high 
and also low sleep pressure was significantly higher in the MDD women than in controls 
(Frey, Birchler-Pedross et al. 2010). Moreover, MDD women responded with a stronger EEG 
synchronization in a frequency range of 0.5-5 Hz during sustained wakefulness during the SD 
(Birchler-Pedross, Frey et al. 2011), which confirmed the higher delta waves during sleep, but 
not the role of delta sleep as a positive predictor for the SD response. In contrast, SWS 
changes in depression, was reported as reduced and SD for one night exerts an immediate 
antidepressant effect that is short lived. Thus, it was hypothesized that sleep regulation 
(Process S) is a deficient depression alleviator (Borbely and Wirz-Justice 1982). 
The antidepressant effect of SD was attributed to the increased level of Process S attained by 
prolonging wakefulness. We could not confirm this hypothesis in our study, since the only 
grounds for this that we could determine could be due to the fact that our cohort of MDD 
women has no sleep disturbances. In this case, we can confirm part of the chronobiological 
model insofar as it is based on the theory of impaired sleep.  
How could our findings be of every day value to the clinician, classified as they are? In 
studies of physiological differences between insomnia with depression versus depression, we 
can conclude, based on these preliminary observations that insomnia with depression and 
depression alone appear to be two distinct entities. There is clinical and epidemiological 
  68 
evidence that sleep disturbances in depression constitute a risk factor for poor clinical 
outcomes. Specifically, insomnia complaints tend to precede the onset and recurrence of 
depression (Perlis, Giles et al. 1997; Cole and Dendukuri 2003; Riemann and Voderholzer 
2003) in as many as 40% of cases (Ohayon and Roth 2003). The risk of developing major 
depression is significantly increased in individuals complaining of insomnia (Dryman and 
Eaton 1991; Breslau, Roth et al. 1996; Mallon, Broman et al. 2000). Sleep disturbances in 
depression can predict treatment outcomes. Specifically, poor sleep quality predicts poor 
response to non-pharmalogical treatments (interpersonal psychotherapy) of depression 
(Buysse, Kupfer et al. 1999). Finally, subjectively reported better sleep quality post-treatment 
is associated with lower rates of recurrence of depression (Buysse, Frank et al. 1997). 
Together, these observations suggest a critical role played by circadian and sleep disturbances 
in the pathophysiology of depression. Insomnia is thereby not only experienced subjectively 
but also reflected in altered objective sleep architecture, as first demonstrated by Kupfer and 
colleagues in the early 1970s (Kupfer and Foster 1972). 
 
CONCLUSION 
The constant routine study conditions allowed us to very precisely measure circadian rhythms 
in mood during a depressive episode. The women with major depression exhibited strong 
diurnal mood variations not found in healthy controls. Even though it has been shown that 
high variability of mood fluctuations is a good predictor of SD response, this group of MDD 
women without sleep disturbances did not respond to SD. These findings indicate that the 
antidepressant response to SD may depend on the magnitude of insomnia present. 
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ABSTRACT 
Background The psychomotor vigilance task (PVT) is a neurobehavioral task that can 
sensitively measure the effects of sleep pressure and circadian phase in healthy individuals. 
However, so far no studies have focused on PVT performance in depressive volunteers under 
differential sleep pressure conditions (sleep deprivation (SD) vs. sleep satiation (NAP). Here 
we examined the effects of high (40-h SD) and low sleep pressure (40-NAP) on PVT 
performance in young women with major depression in comparison to healthy controls.  
Methods Eight healthy women (mean age 25±3.3y) and eight women (mean age 24±4.8y) 
with MDD underwent 40-h SD (high sleep pressure) and a 40-h multiple nap paradigm (low 
sleep pressure with intermittent 150/75 minutes of scheduled sleep-wake episodes) under 
constant routine conditions. In both protocols, PVT performance was regularly measured 
during 5 minutes in 11 tests conducted every 225 minutes.  
Results Depressed women had significantly faster reaction time (RT), as indicated by 
significantly lower median, 10%-fastest and 10%-slowest RT (main factor ‘group’, p=0.05) 
during high sleep pressure conditions. No significant differences between the depressed and 
control women were elicited during low sleep pressure conditions in the nap protocol. The 
interaction “time-of-day” x “group” yielded no differences in both protocols, however, when 
considering time-of-day effects; depressed women were comparatively faster in the three 
abovementioned RT variables under both protocols. 
Conclusion Depressed women had faster RT in PVT performance during sleep deprivation. 
This may imply that depressed women are less susceptible to the wake-dependent detrimental 
aspects on PVT performance than non-depressed women. In other words, PVT performance 
in depression may not be directly linked to well-known “prefrontal tiredness”, but rather 
involve subcortical structures and/or reflect higher cognitive arousal caused by rumination.  
 
Keywords: PVT, Major Depression Disorder, Sleep Deprivation, Constant routine. Nap 
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INTRODUCTION 
Sustained attention is fundamental for optimal cognitive functioning. Neurobehavioral and 
cognitive functioning appear to be strongly influenced by two non-additive and interlinked 
systems: the circadian timing system and the homeostatic sleep regulatory system. The 
interplay of these two processes determines the timing, duration, and quality of sleep and 
wakefulness and leads to a characteristic circadian performance pattern in several 
neurobehavioral tasks, such as the psychomotor vigilance task (PVT). Circadian rhythmicity 
has been elicited for a wide range of neurobehavioral variables, such as vigilance and choice 
reaction time for a review see (Rogers, Dorrian et al. 2003), with a minimum close to the 
nadir of core body temperature.  
Sleep deprivation can negatively impact on cognitive performance, particularly in cognitive 
tasks which rely on prefrontal cortex (PFC) function for review (Rogers, Dorrian et al. 2003). 
Continuous load on PFC activation enhances its susceptibility to „deterioration” with elapsed 
time awake (Harrison, Horne et al. 2000) which in turn can be associated with decreased 
higher cognitive performance, such as executive function (Drummond, Bischoff-Grethe et al. 
2005), and also cognitive processes involving speed and attentional accuracy. Many previous 
studies have shown impairments on a diverse range of cognitive functions such as memory, 
planning and executive attention (Weingartner, Cohen et al. 1981). These cognitive functions 
belong to the brain region of frontal cortex. Prominent models of neurobiology of depression 
implicate involvement of the anterior cingulated cortex (ACC) and the dorsolateral prefrontal 
cortex (DLPFC). 
Reaction time in PVT performance shows clear dose-response sleep deprivation effects, as 
indexed by lengthier RT with partial sleep deprivation, which becomes progressively more 
lengthened with longer deprivation periods (Dinges, Pack et al. 1997; Beaumont, Batejat et al. 
2001). The theoretical underpinnings may involve decreased arousal as indicated by increased 
sleep pressure leading to inconsistent performance (greater response variability with lapses on 
RT and sustained attention tests) and wake-state instability. In the former, increased 
propensity to sleep may negatively impact on frontal lobes leading to behavioural lapses; 
response slowing, time-on-task decrements, and errors of commission (Saper, Chou et al. 
2001). In the latter, cognitive performance variability may reflect wake state instability 
(Saper, Chou et al. 2001) according to which sleep-deprived individuals undergo reciprocally 
inhibiting neurobiological systems that mediate sleep initiation and wake maintenance 
(Mignot, Taheri et al. 2002). This can be indicated by vigilance tasks with longer RT and 
increased errors of omission at longer time intervals.  
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Taken together, the above mentioned data suggest that cognitive performance decrements in 
vigilance tasks depend heavily on the level of the sleep–wake homeostat. While there is 
substantial body of evidence in favour of performance decrements in healthy volunteers, it is 
striking that currently no studies have focused on the PVT performance in depressive 
volunteers under sleep deprivation (SD) condition. Thus, our aim was to elucidate how the 
sleep-wake homeostat and the circadian system can impact on PVT performance and 
subjective alertness in depressed individuals, under stringent controlled laboratory conditions, 
during 40-h of sleep deprivation and 40-h of sleep satiation (multiple nap protocol, NAP). We 
hypothesised as follows: 
1. Depressed women show worse psychomotor vigilance performance than controls.  
However, this difference disappears with accumulating sleep pressure in the high sleep  
pressure protocol, due to the higher “prefrontal tiredness”. 
2. Psychomotor vigilance performance under low sleep pressure will be constantly  
 reduced in depressed women compared to controls. 
3. The improvement in psychomotor vigilance performance during high sleep pressure  
 conditions in depressed women correlates with the antidepressant effect of sleep  
 deprivation. 
4. Depressed women will undergo inferior physical comfort than healthy controls during  
 the PVT performance under high sleep pressure condition. 
 
 
METHODS  
Study participants  
All study participants were recruited via advertisements at different Swiss universities and on 
online jobs advertisements pages for students. A total of 16 young women (mean age 26±5y) 
have participated in the study. All 16 young women were suffering from an episode of Major 
Depression Disorder (MDD) during the study protocol: they fulfilled the diagnostic criteria of 
DSM-IV for MDD, with no atypical symptoms, and without other co-morbid psychiatric 
DSM-IV-disorders. Each of the participants underwent a clinical interview including the 
SKID-Interview (Wittchen, Wunderlich et al. 1997), a structured interview for the Hamilton 
Depression Scale (SIGH-ADS, Hamilton-17) (Janet, Williams et al. 2003), Montgomery 
Åsberg Depression Scale (MADRS) (Montgomery and Asberg 1979), Beck Depression 
Inventory (BDI) (Beck, Ward et al. 1961). All the depressive subjects had a mean value of 
BMI 22.07±3.2SD and a mean of chronotype of 15.88±1.35SD. 
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The healthy cohort comprised eight young subjects (8 women age range 20-31 years; mean 
age 25±3.3years [SD]. For detailed information of the control subjects please see (Knoblauch, 
Martens et al. 2003). 
All subjects non-smokers, free from medical, psychiatric, neurologic and sleep disorders 
(Pittsburgh Sleep Quality Index score<8) (Buysse, Reynolds et al. 1989)and average 
chronotypes (score between 14 and 21) as assessed by screening questionnaires, a physical 
examination and a polysomnographically recorded screening night. Inclusion criteria included 
volunteers with no sleep disorders[apnoea/hypopnoea-index (AHI) <10/h; periodic leg 
movements (PLM) index <10/h]. Participants were also required to abstain from excessive 
caffeine and alcohol consumption as well as heavy physical exercise. Other exclusion criteria 
were: shift work within 3 months and transmeridian flights within 1 month prior to the study.  
Subjects started the study on days 1–5 after menses onset in order to complete the entire study 
block within the follicular phase. Three depressive and five control subjects were taking oral 
contraceptives.  
All procedures conformed to the Declaration of Helsinki. The local Ethical Committee 
approved the study protocol, screening questionnaires and consent form [for details see 
(Munch, Knoblauch et al. 2004)], and all study participants gave signed informed consent.   
 
Protocol and study design 
Each participant was instructed to maintain a regular sleep–wake cycle (bed- and wake-times 
within ±30 min of self-selected target time), which was verified by wrist activity monitors 
(Cambridge Neurotechnology®, UK) and sleep logs during one week prior to the study. The 
study design entailed two protocols: one for high and one for low sleep pressure condition. In 
each protocol, we included eight control and eight depressive subjects. During day 1 subjects 
adjusted to the experimental dim light condition (<8 lux); one depressive subject received a 
low-dose heparin injection on two consecutive days of each study block (Fragmin® 0.2 ml, 
2500 IE/Ul, Pharmacia AG, Dübendorf, Switzerland) in order to prevent venous thrombosis. 
After a second 8-h sleep episode, all subjects participated in a 40-h  sleep deprivation protocol 
under chronobiological controlled conditions as detailed in (Cajochen, Khalsa et al. 1999) 
which was followed by a recovery night. The 8-h sleep episode was calculated with respect to 
the midpoint of each individual’s habitual sleep episode as assessed by actigraphy and sleep 
logs during the baseline week. All wake episodes were spent under semi-recumbent CR 
conditions (<8 lux) during wakefulness with a minor shift to supine posture during scheduled 
sleep episodes (0 lux). 
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Psychomotor vigilance task 
The PVT task is a sustained attention performance task (Dinges, Pack et al. 1997) sensitive to 
sleep loss and circadian rhythmicity (Dinges, Pack et al. 1997). The study participants are 
required to quickly press a button as soon as red digits appear on a millisecond counter. The 
digits are presented in intervals randomly varying from 3 to 7 s. During both protocols, 11 test 
bouts of 5 minutes duration were performed every 225 min starting 75 min lights on in the 
morning. In the NAP condition the PVT was scheduled 75 min before and after each nap. All 
participants were instructed to press the response button as fast as possible as the red digits 
appeared. 
 
Subjective alertness comprised subjective experience of feeling alert as indexed by the visual 
analogue scale “very alert to not at all alert”, which can be assessed using likert-type self-
rating scale such as the Karolinska Sleepiness Scale (KSS) (Akerstedt and Gillberg 1990). 
 
Data Analyses and Statistics 
We analyzed median RT, mean of 10% fastest, and of the 10% slowest RT’s, all converted to 
reciprocal RT’s. In addition, we calculated the interpercentile range between the 10th and 90th 
percentile according to (Graw, Krauchi et al. 2004). In a first step, a two way ANOVA 
analysed by Procedure Mixed with the repeated factors “elapsed time” (session 1 to 11) and 
the between factors “group” was performed for each protocol separately. All derived p-values 
were based on the Huynh-Feldt’s corrected degrees of freedom Alpha criterion was set at 
p=0.05. SAS® (SAS Institue Inc., Cary, NC, USA; Version 9) and Sigma plot® to visualize 
data (SIGMA plot Version 9). 
 
RESULTS 
Psychomotor vigilance task (PVT): Main factor “group” yielded significant differences for 
global mean value of Reaction Time (RT) for both protocols ( p=0.0097 for SD, p<0.001 for 
NAP). The Interpercentile range did not differ in either in both protocols, however, main 
factor group yielded significant differences for three dependent RT variables (median, 10%-
fastest and 10%-slowest RT, p=0.05), with significantly faster reaction time for the depressive 
cohort in SD protocol, although no group-effect differences were elicited for the nap 
condition. Time of day yielded significant differences for both protocols, although the 
interaction of the “time of day” and “group” indicated no differences under both protocols. 
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Table 1 illustrates the results of the rANOVAs of the measures ‘median RT’, ‘10% slowest 
RTs’, ‘10% fastest RTs’, and the interpercentile range (10th–90th percentile). 
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Figure 5.1: Median RT (ms) of the depressed and control group under low (Nap) and high (SD) sleep pressure 
conditions. 
 
 
Factors Reaction Time 
(Median, p50) 
Reaction Time 
(10% fastest, p10) 
Reaction Time 
(10% slowest, p90) 
Reaction  
Time (Inter- 
percentile range 
10th-90th) 
Time of day 
(SD) 
sign. p=0.0005 sign. p=0.0005 sign. p=0.0172 n.s. 
Time of day 
(NAP) 
sign. p=0.0002 sign. p=0.0006 sign. p=0.0028 n.s. 
group 
(SD) 
sign. p=0.048 sign. p=0.0266 sign. p=0.0417 n.s. 
group 
(NAP) 
n.s. n.s. n.s. n.s. 
Time of day x group (SD) n.s.  n.s. n.s. n.s. 
Time of day x group 
(NAP) 
n.s. n.s. n.s. n.s. 
 
Table 5.1: Results of the r ANOVAs of the measures "median RT", 10%slowest RTs", "10%fastestRTs", and the 
interpercentile range (10th-90th percentile) 
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Figure 5.2: Time course of vigilance performance exemplified by median reaction time of depressed and the 
controls under low (NAP) and high (SD) sleep pressure conditions upper panel. Time course of subjective 
alertness (100- mm visual analogue scale) during the 40-h high sleep pressure protocol (upper panel) and 
during the 40-h low sleep pressure protocol (lower panel). Mean values ± SEM. Depressed patients are plotted 
in dots, the healthy controls with open symbols. 
 
Subjective alertness (VAS): Regarding the time course of subjective alertness, the depressive 
young women rated their alertness not different from the control group during the high sleep 
pressure  illustrated in the top panel of figure 2 neither and during the low sleep pressure 
illustrated in Figure 3 top panel, which devoted no statistically significant ‘group‘ effect 
(p=0.5). The ‘time of day’ in subjective sleepiness yielded a very significant value (p<.0001), 
which shows the expected modulation of alertness during wakefulness in both groups. The 
interaction of the two-way rANOVA for the factors group and time of day was not significant 
(p=0.4).  
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DISCUSSION 
The main finding of this study is that depressed women show a comparatively faster 
performance in the PVT under high sleep pressure condition. This is strikingly unusual when 
one has in mind that depression is more frequently associated with cognitive decrements, 
particularly in tasks involving PRC function. Furthermore, circadian rhythms in depression, as 
indicated by attenuated melatonin amplitude during sustained wakefulness (Birchler-Pedross, 
Frey et al. 2011), appear to indicate that depressed women may undergo a weakened circadian 
arousal signal that does not appropriately oppose the sleep homeostatic process, which is 
related to higher subjective tension. Considering these factors, why does PVT performance in 
our depressed subjects go in an opposite direction? Within a psychological framework, 
depressed patients with alertness problems frequently complain about higher levels of 
tiredness and lower capability to cope with stress, which can suggest that individuals who feel 
subjectively sleepier are also more cognitively impaired (Leproult, Colecchia et al. 2003). 
However, this assumption may not hold true. Accumulating evidence indicates that subjective 
sleepiness and objective alertness are not necessarily related to performance measures during 
sleep deprivation protocols (Frey, Badia et al. 2004) showed that depressive subjects need 
more time for cognitive decision but not for motor speed reaction time, which may partially 
underlie our findings. In other words, while depressed subjects experience symptoms of “loss 
of interest”, “loss of energy”, “loss of motivation” this does not necessarily imply that tasks 
focused on quick motor reaction times, such as very short RT of the PVT, will exhibit a 
decrement. We do not have the true explanation for the faster PVT performance in depressed 
young women. The faster performance may be correlated to the very short task duration of 5 
minutes. It has to be assumed that depressive patient will be slower while the task duration 
expanses. 
Other line of reasoning builds up from discrepancies between “sleepiness” and “alertness”.  
These constructs are often assumed to be reciprocal states of consciousness e.g. (Moller, 
Devins et al. 2006). Alertness and sleepiness are not necessarily reciprocal states, since 
studies have indicated that subjective states of impaired alertness and excessive sleepiness are 
independent constructs in the evaluation of sleep-disordered patients e.g. (Moller, Devins et 
al. 2006), Sleepiness and alertness states are in the background of most cognitive processes, 
even if not systematically modulating performance. Measures of subjective sleepiness are 
generally sensitive to decreased alertness and performance decrements during sleep 
deprivation but are weakly correlated to performance on RT, vigilance and cognitive tasks in 
individuals (Binks, Waters et al. 1999). The effects of sleep deprivation on other cognitive 
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tasks were less consistent than the effects on RT and vigilance tasks. To some extent this lack 
of consensus is due to different experimental conditions, length of testing battery, difficulty of 
the task. Drummond et al., (Drummond, Meloy et al. 2005) found that particularly poor 
performance after sleep deprivation may elicit a subsequent attentional recovery that 
manifests itself as greater activation within the brain regions normally responsible for fast 
reaction times. Furthermore, even factors such as body posture influence RT. RT performance 
in overnight sleep deprived subjects is slowed when seated, but normal when standing 
(Caldwell and Gilreath 2002). The effects of sleep deprivation are complicated by the 
interaction of diurnal variation (circadian phase) with monotonic effects (length of sleep 
deprivation), consistent with the two-process model proposed by Borbély (Achermann and 
Borbely 2003) (Cajochen, Khalsa et al. 1999). Also, effects of sleep deprivation on 
performance are not uniform and there is considerable inter subject variability, likely 
representing individual characteristics (Bonnet and Arand 2005). 
A cortical hallmark of neurobehavioral functioning is the prefrontal cortex (PFC). A number 
of performance tasks thought to be putatively subserved by the PFC have been reported to 
demonstrate significant impairment during sleep loss, which is reversible following recovery 
sleep (Harrison, Horne et al. 2000). This has been corroborated by anatomical evidence that 
the central pacemaker located in the SCN plays a major role in the regulation of arousal and 
attention through noradrenergic mechanisms (Aston-Jones, Rajkowski et al. 1999) (Aston-
Jones, Chen et al. 2001) (Doran, Van Dongen et al. 2001) (Harrison and Horne 1998). The 
SCN projects to the PFC (Sylvester, Krout et al. 2002), via its relay in the paraventricular 
thalamic nucleus (PVT) to the medical PFC in rats. Assuming that a homologous circuit exists 
in humans, these pathways may modulate high level brain functions, such as attention or 
working memory. This could explain the effects of circadian phase per se on neurobehavioral 
function and sleepiness, which have been reported in non-sleep deprived subjects during 
forced desynchrony protocols (Wyatt, Ritz-De Cecco et al. 1999) and multiple nap studies 
(Cajochen, Knoblauch et al. 2001) (Cajochen, Knoblauch et al. 2001); (Lavie 1986).  
A further aspect to explain our conflicting results could be motivation during neurobehavioral 
performance. One psychological construct with is underlying brain systems impacting 
sustained attention is motivation. Based on animal as well as human lesion studies, the 
motivational system includes portions of the frontal lobes (e.g. anterior cingulated) as well as 
limbic and subcortical structures (striatum, nucleus accumbens, and amygdala) and much of 
the dopamine system (Robbins and Everitt 1999). Subjects who are apathetic or unmotivated 
will not be as vigilant as those with high motivation. Performing task with a high financial 
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reward for performance engages the attention system stronger and with longer duration than 
performing the same task with no overt reward for performance (Homberg, Grunewald et al. 
1981) (Begleiter, Porjesz et al. 1983). Conceptually, effort (Kahneman 1973) and motivation 
are related. Several factors modify the effects of sleep deprivation on RT and vigilance task 
performance. Long, simple low-interest, self-paced RT tests are most affected by sleep loss.  
The effects on RT are partially reversed when there is feedback provided when the task is 
shorter or more challenging, or when there is a reward used as incentive for performance, 
suggesting that increased motivation or interest can at least partially compensate for the 
effects of sleep deprivation (Steyvers and Gaillard 1993). Taken together, one might speculate 
that tasks of short duration may engage depressed subjects to obtain a better performance.  
Another explanation as to why depressive subjects are faster in PVT could be explained by 
the effects of Total Sleep Deprivation (TSD). TSD appears to be simultaneously arousing 
(energy-giving) and de-arousing (leading to less tension), while this response takes place 
against a background of increased tiredness/sleepiness. It is argued that TSD triggers a 
psychological disinhibition process on cortical fatigue, most possibly due to a dampening of 
subcortical arousal systems (Van Den Burg, Beersma et al. 1992) although prefrontal cortical 
areas may also be implicated. The rapid, usually-short lasting improvement of depressive 
symptoms (Wirz-Justice and Van den Hoofdakker 1999), which in turn could be an 
underlying reason for subjects to experience task engagement; can not explain this faster 
performance of the depressive subjects. 
While speed performance on simple repetitive (Colquhoun 1981) and serial search tasks 
(Monk 1982) peaks with temperature levels in the evening, speed performance on more 
complex cognitive tasks (e.g. logical reasoning tasks (Folkard 1975)) peaks in the late 
morning, and performance in short-term memory retention peaks in the early to mid-morning 
e.g. (Laird and McClumpha 1925) .These findings led to the hypothesis that the time of day at 
which a cognitive test is optimally completed is largely dependent on the specific parameters 
of the task, including the cognitive domain it belongs to, is duration and difficulty, the 
administration method, and the measured variable (Bonnet 2000). This and many other 
studies disclosed a temporal relationship between circadian variations in cognitive 
performance measures and daily fluctuations in physiological variables, such as when core 
body temperature (CBT) is high, neurobehavioral performance levels also tend to be high, 
whereas low CBT or high endogenous melatonin secretion are associated with reduced levels 
of neurobehavioral performance and alertness. (Kleitman, Titelbaum et al. 1938) explained 
this association by arguing that accuracy and speed in performance are contingent upon levels 
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of muscle tonicity and in turn on the metabolic activity of the cells of the cerebral cortex.  He 
therefore surmised that raising the latter through the circadian related increase in body 
temperature would indirectly speed up cognitive processing. This findings could help for 
another interpretation of our data such as that we found under SD lower levels of melatonin 
(Birchler-Pedross, Frey et al. 2011) and a tendency to higher core body temperature (Frey 
unpublished data) which could explain the faster reaction time. Although the circadian driven 
temperature oscillator is certainly one determinating factor of subjective vigilance, it is also 
influenced by the homeostatic process controlling the sleep-wake cycle.  
 
CONCLUSION 
Depressed women had faster RT in PVT performance during sleep deprivation. This may 
imply that depressed women are less susceptible to the wake-dependent detrimental aspects 
on PVT performance than non-depressed women. In other words, PVT performance in 
depression may not be directly linked to well-known “prefrontal tiredness”, but rather involve 
subcortical structures and/or reflect higher cognitive arousal caused by rumination 
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CHAPTER 6  
 
General Discussion 
In this thesis, the theoretical framework that underpins depression is addressed within the 
context of the circadian and sleep-wake homeostatic regulation, and on how these two 
independent and non-additive systems impact mood, subjective sleepiness, melatonin and 
waking EEG in young depressive women. 
 
Circadian and sleep-wake homeostatic repercussions on subjective well-
being are age and gender dependent 
Chapter 2 focuses on a model of how the circadian and homeostatic systems interact on 
subjective well-being, subjective sleepiness, melatonin and cortisol in young and older 
healthy subjects. I could successfully prove that our study design (40-h SD and 40-h nap 
protocol under constant routine conditions) was sensitive enough to quantify circadian and 
homeostatic influences on subjective well-being (i.e. composite score of mood, tension and 
physical comfort). Furthermore, I could show that the well known circadian regulation of 
subjective sleepiness, melatonin and cortisol are clearly age and gender dependent in healthy 
adult volunteers. Time of day modulation of subjective well-being was prominent in both the 
SD and the nap protocol participants, indicating that circadian phase plays a pivotal role in 
well-being. This is in accordance with data from a forced desynchrony protocol in which a 
significant component of mood regulation could be educed (Boivin, Czeisler et al. 1997). In 
general, and as a new interesting finding, both older adults and women were more affected by 
SD, showing a tendency to lower subjective well-being and a prominent circadian trough. The 
time course of subjective well-being displayed a significant circadian modulation, particularly 
in women under high sleep pressure conditions. Based on the results of young women and 
older volunteers, I hypothesized that the circadian dysregulation and sleep disturbances 
associated with depression may have profound detrimental effects on mood in depressed 
patients and older people, thus further perpetuating the disorder. However, this assumption 
could not be confirmed by results described in chapters 3 to 5. In chapter 2, subjective-well 
being was also compared with other circadian parameters such as sleepiness, cortisol and 
melatonin. These results indicate that subjective sleepiness and cortisol levels were 
significantly correlated with subjective well-being. Night time melatonin secretion in older 
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volunteers was significantly lower than in the young, and all volunteers had slightly but 
significantly higher melatonin levels during the low (nap) than the high (SD) sleep pressure 
protocol. Although significant, the latter has probably no clinical relevance since the 
differences between SD and nap were rather small (< 2 pg/ml). However, in terms of 
melatonin, the most surprising result was that young women had significantly higher levels of 
nocturnal melatonin than young men and older men and women. The latter was not dependent 
on menstrual cycle, since another study in our laboratory yielded similar nocturnal melatonin 
levels in women studied during another phase of the menstrual cycle. 
After the successful completion of the SD and the nap protocol in healthy young and older 
volunteers, we decided to apply exactly the same study design in young women suffering 
from an episode of major depression to test circadian and homeostatic related hypotheses that 
we formulated based on the previous literature (please see introduction) on depression. 
 
I could identify many new and unexpected results regarding the influence of circadian and 
homeostatic effects on major depression (chapter 3 and 4). Some of the results of this thesis 
did not confirm the postulated hypothesis (please see Aims and Hypothesis of the Studies B). 
In the following I will briefly elucidate on the most interesting and surprising results and 
discuss them with respect to the previously postulated hypothesis and what it could imply for 
future treatments.  
 
Possible impairments of sleep-wake homeostasis in depression 
measured by the EEG during wakefulness 
In chapter 3, I focussed on the hypothesis that a deficiency in the homeostatic build-up of 
sleep pressure during sustained wakefulness (i.e. SD) could occur in depression, which in turn 
is responsible for less sleep intensity and thus less restful sleep. In contrast to a deficiency of 
the homeostatic process (i.e. S-deficiency), the results of this thesis rather indicated that 
depressed women might live on a higher level of homeostatic sleep pressure, as indexed by 
enhanced high frontal-low EEG activity (delta range from 2 to 5 Hz) during sustained 
wakefulness in the SD protocol. This finding of a higher sleep pressure in depressed was also 
supported by a tendency to have higher sleep pressure levels during the nap protocol 
((Birchler-Pedross, unpublished data) illustrated in Figure Appendix 1). Along these line, we 
have evidence for significantly higher EEG slow-wave activity (delta EEG activity) levels in 
NREM sleep in the depressed cohort during baseline and recovery sleep in both the SD and 
the nap protocol (Frey, unpublished data). 
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Since mostly frontal brain areas were affected and these brain areas are particularly 
susceptible to the effects of sleep loss and quality of wakefulness, we interpret our results as 
reflecting a greater need for sleep, a different quality of wakefulness and/or less efficient sleep 
in our depressed women. For the latter however, we do not have statistical evidence, since 
sleep efficiency >90% was the same in both the control and the depressed women. Analysis of 
the microstructure of the sleep EEG, however, revealed that depressed women had more 
short-term arousals, which were not considered in the traditional sleep scoring analyses 
(analyses in progress). Thus, elevated slow-wave activity during NREM sleep could also 
reflect an immediate compensatory homeostatic response to these short-term arousals, a 
phenomenon, which was recently reported for primary insomnia (Parrino, Ferrillo et al. 2004). 
Another underlying reason may be a use-dependent phenomenon, for example, the enhanced 
rumination in depression, which reinforces frontal delta activity. Although, in this project, we 
did not measure the degree of rumination via questionnaires, the depressed women expressed 
in general more concerns about the study protocol and every day matters than our control 
women. 
In addition to the EEG, we also have evidence that the depressed women of this study were 
sleepier and tenser than the control women, thus contributing towards a significant effect 
during the biological night. Another unexpected finding was a significantly reduced night 
time secretion of salivary melatonin during sustained wakefulness in the depressed compared 
to the control women. This tendency to lower amplitude of melatonin could manifest a weaker 
circadian alerting signal, which manifests itself particularly in the late evening and thus 
allows more frontal delta activity. Another explanation could be that depressed women spend 
more time under artificial light conditions and less time under outdoor conditions than the 
controls prior to the study. Timing of melatonin onset (i.e. circadian phase) was not different 
compared to the control women. A possible explanation of the “non shift” in circadian phase 
might be an intact biological clock and/or the proposed selection of intermediate chronotypes 
for this study. Interestingly, we had to exclude many potential depressed study participants, 
due to a too late chronotype. Figure 6.1 illustrates the distribution of the interested volunteers.  
Thus, the study was biased in this regard, since the likelihood of being a late chronotype 
seems to be enhanced in depressed women. Interestingly, the randomly selected depressed 
subjects in the high sleep pressure protocol show in their distribution of intermediate 
chronotype a tendency to late type. This fact could have a profound influence on the 
amplitude of melatonin, which is lower during SD. Several studies, which found a phase-shift 
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in depression, did not account for chronotypes. Thus, if a study determines phase shifts in 
depressed women or not, will strongly depend on the selection criteria. 
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Figure 6.1: Illustration of the distribution of the chronotypes from the study applicants (unpublished data). 
  
Diurnal mood variation and antidepressant effect of sleep deprivation 
In chapter 4, I investigated if SD ameliorates mood as has been postulated in many studies 
(Wirz-Justice and Van den Hoofdakker 1999). The data show that depressed women without 
sleep disturbances show a significantly different time course of mood during the SD protocol 
(i.e. high sleep pressure) but not during nap protocol (i.e. low sleep pressure). Under SD they 
exhibited a more distinct circadian modulation of lower mood than controls. In their diurnal 
modulation they showed morning worsening and evening improvement, which corresponds to 
the so-called melancholic type. Despite this higher variability of mood fluctuation and 
characteristic of a more melancholic type as a predictor of SD response, surprisingly, and in 
contrast to my hypothesis, they did not profit from an antidepressant effect. These findings 
indicate that the possible profit of a treatment with SD could depend on the magnitude of 
insomnia in depression. 
 
Neurobehavioral performance during sustained wakefulness in 
depression 
In chapter 5 I focused on the influence of high and low sleep pressure conditions on 
neurobehavioral performance in depressed using the PVT. These results yielded an 
unexpected finding: depressed women had faster RT in PVT performance during SD. This 
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may imply that depressed women are less susceptible to the wake-dependent aspects in PVT 
performance. This implies that PVT performance in depression may not be directly linked to 
well-known “prefrontal tiredness”, which includes higher cognitive functions (executive, 
attention, memory), but rather that subcortical structures are involved in this process. 
Furthermore, this faster RT may also reflect higher cognitive arousal due to rumination seen 
in the higher frontal delta activity (chapter 3) and intensified by higher subjective tension 
(chapter 3). This assumption can be confirmed with results by Horne (Horne 1988). 
Accordingly, the maintenance of cognitive performance after SD is accompanied by a 
significant increase in muscle tension. Another aspect that should be taken into account is the 
duration of the task. Given that the PVT performance lasted only 5 minutes, it can be 
speculated that the depressed women performed faster since they can usually maintain their 
alertness for short time durations. Another possible explanation could be that increased 
motivation or interest can at least partially compensate for the effect of SD (Steyvers and 
Gaillard 1993). Unfortunately, in this study, we have not examined motivation by 
questionnaire. I do not have a true explanation for the faster PVT performance in depressed 
young women under high sleep pressure.  
 
Conclusion and Perspectives 
Taken together, this thesis provides several surprising data that conflict with some long-
standing mainstream hypotheses (chapters 3 – 5). Overall, the homeostatic process seems to 
strongly influence young women with major depression disorder, as indicated by enhanced 
high frontal low-EEG activity. Higher subjective sleepiness and lower concentration of 
salivary melatonin amplitude during biological night of the depressed indicated that they did 
not profit from the antidepressant effect yet performed faster in PVT during SD. The waking 
EEG data suggests that the sleep-wake homeostat of the depressed is more an overdrive than 
an S-deficiency, which probably corresponds to the clinically reported day time fatigue. 
Depressed women who live on a higher level of sleep pressure do not profit from the 
antidepressant effect of SD and perform faster in a reaction time task than controls. This leads 
to the assumption that the excluded factors in this protocol (chronotype, insomnia) may exert 
a strong influence on the results. Considering the suggestion that hypocretin neurons stabilise 
arousal/alertness during periods of wakefulness and increase arousal-related behaviours, then 
it would be reasonable to regard it as an endogenous stressor. The heuristic model of 
emotional and physiological hyperarousal hypothesis (Basta, Chrousos et al. 2007) must be 
assumed, since the depression cohort in this study suffered only a minor hyperarousal, which 
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probably affects frontal delta activity, leads to a higher sleep pressure but is not strong enough 
to cause sleep disturbances. The postulated abnormalities (i.e. phase-shift, sleep disturbances) 
in the biological rhythms seem to undergo less dramatic differences in the young depressed 
women who were investigated in this study; hence, it can be assumed that the homeostatic 
process seems to be more influential than previously thought. 
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Figure Annex 1: 
2               6                9              13              17              21              24              28             32              36              39 
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Time of Day (h)
Red colour = MDD women
Blue colour = controls
 
  
Figure Annex 1: Time course of low-frequency EEG activity (in the range of 0.5-5Hz), during the 40 h nap 
protocol (low sleep pressure). These contour plots (i.e., heads) describe the difference between loe-frequency 
EEG activity in the MDD (red colour) and healthy control women (blue colour) over the 11 time points 
(Birchler-Pedross unpublished data). 
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